
<html lang="en"     class="pb-page"  data-request-id="e5b30c5c-a907-4a54-9ca2-2941b49f4c40"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.6b00703;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension" /></meta><meta name="dc.Creator" content="Duncan E.  Shaw" /></meta><meta name="dc.Creator" content="Ferheen  Baig" /></meta><meta name="dc.Creator" content="Ian  Bruce" /></meta><meta name="dc.Creator" content="Sylvie  Chamoin" /></meta><meta name="dc.Creator" content="Stephen P.  Collingwood" /></meta><meta name="dc.Creator" content="Sarah  Cross" /></meta><meta name="dc.Creator" content="Satish  Dayal" /></meta><meta name="dc.Creator" content="Peter  Drückes" /></meta><meta name="dc.Creator" content="Pascal  Furet" /></meta><meta name="dc.Creator" content="Vikki  Furminger" /></meta><meta name="dc.Creator" content="Deborah  Haggart" /></meta><meta name="dc.Creator" content="Martin  Hussey" /></meta><meta name="dc.Creator" content="Irena  Konstantinova" /></meta><meta name="dc.Creator" content="Jon C.  Loren" /></meta><meta name="dc.Creator" content="Valentina  Molteni" /></meta><meta name="dc.Creator" content="Sonia  Roberts" /></meta><meta name="dc.Creator" content="John  Reilly" /></meta><meta name="dc.Creator" content="Alex M.  Saunders" /></meta><meta name="dc.Creator" content="Rowan  Stringer" /></meta><meta name="dc.Creator" content="Lilya  Sviridenko" /></meta><meta name="dc.Creator" content="Matthew  Thomas" /></meta><meta name="dc.Creator" content="Christopher G.  Thomson" /></meta><meta name="dc.Creator" content="Christine  Tomlins" /></meta><meta name="dc.Creator" content="Ben  Wen" /></meta><meta name="dc.Creator" content="Vince  Yeh" /></meta><meta name="dc.Creator" content="Andrew C.  Pearce" /></meta><meta name="dc.Description" content="A series of potent PDGFR inhibitors has been identified. The series was optimized for duration of action in the lung. A novel kinase occupancy assay was used to directly measure target occupancy af..." /></meta><meta name="Description" content="A series of potent PDGFR inhibitors has been identified. The series was optimized for duration of action in the lung. A novel kinase occupancy assay was used to directly measure target occupancy af..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 19, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00703" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00703" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00703" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00703" /></link>
        
    
    

<title>Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00703" /></meta><meta property="og:title" content="Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0021.jpeg" /></meta><meta property="og:description" content="A series of potent PDGFR inhibitors has been identified. The series was optimized for duration of action in the lung. A novel kinase occupancy assay was used to directly measure target occupancy after i.t. dosing. Compound 25 shows 24 h occupancy of the PDGFR kinase domain, after a single i.t. dose and has efficacy at 0.03 mg/kg, in the rat moncrotaline model of pulmonary arterial hypertension. Examination of PK/PD data from the optimization effort has revealed in vitro:in vivo correlations which link duration of action in vivo with low permeability and high basicity and demonstrate that nonspecific binding to lung tissue increases with lipophilicity." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="A series of potent PDGFR inhibitors has been identified. The series was optimized for duration of action in the lung. A novel kinase occupancy assay was used to directly measure target occupancy after i.t. dosing. Compound 25 shows 24 h occupancy of the PDGFR kinase domain, after a single i.t. dose and has efficacy at 0.03 mg/kg, in the rat moncrotaline model of pulmonary arterial hypertension. Examination of PK/PD data from the optimization effort has revealed in vitro:in vivo correlations which link duration of action in vivo with low permeability and high basicity and demonstrate that nonspecific binding to lung tissue increases with lipophilicity." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0021.jpeg" /></meta><meta name="twitter:title" content="Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00703"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00703">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00703&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00703&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00703&amp;href=/doi/10.1021/acs.jmedchem.6b00703" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7901-7914</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00682" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00722" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Duncan+E.++Shaw">Duncan E. Shaw</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ferheen++Baig">Ferheen Baig</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian++Bruce">Ian Bruce</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvie++Chamoin">Sylvie Chamoin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+P.++Collingwood">Stephen P. Collingwood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Cross">Sarah Cross</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Satish++Dayal">Satish Dayal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Dr%C3%BCckes">Peter Drückes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Furet">Pascal Furet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vikki++Furminger">Vikki Furminger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Haggart">Deborah Haggart</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Hussey">Martin Hussey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irena++Konstantinova">Irena Konstantinova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jon+C.++Loren">Jon C. Loren</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valentina++Molteni">Valentina Molteni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sonia++Roberts">Sonia Roberts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Reilly">John Reilly</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alex+M.++Saunders">Alex M. Saunders</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rowan++Stringer">Rowan Stringer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lilya++Sviridenko">Lilya Sviridenko</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Thomas">Matthew Thomas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+G.++Thomson">Christopher G. Thomson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Tomlins">Christine Tomlins</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Wen">Ben Wen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vince++Yeh">Vince Yeh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+C.++Pearce">Andrew C. Pearce</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Novartis Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>‡</sup>Metabolism and Pharmacokinetics, <sup>§</sup>Global Discovery Chemistry, and <sup>#</sup>Respiratory Diseases, NIBR Horsham, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">∥</span> <span class="aff-text">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">⊥</span> <span class="aff-text">Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>Telephone: +1 6178717739. E-mail: <a href="/cdn-cgi/l/email-protection#f99d8c979a9897d78a91988eb997968f988b8d908ad79a9694"><span class="__cf_email__" data-cfemail="3256475c51535c1c415a5345725c5d445340465b411c515d5f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00703&amp;href=/doi/10.1021%2Facs.jmedchem.6b00703" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7901–7914</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 9, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 May 2016</li><li><span class="item_label"><b>Published</b> online</span>19 August 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 September 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00703" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00703</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7901%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDuncan%2BE.%2BShaw%252C%2BFerheen%2BBaig%252C%2BIan%2BBruce%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D17%26contentID%3Dacs.jmedchem.6b00703%26title%3DOptimization%2Bof%2BPlatelet-Derived%2BGrowth%2BFactor%2BReceptor%2B%2528PDGFR%2529%2BInhibitors%2Bfor%2BDuration%2Bof%2BAction%252C%2Bas%2Ban%2BInhaled%2BTherapy%2Bfor%2BLung%2BRemodeling%2Bin%2BPulmonary%2BArterial%2BHypertension%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7914%26publicationDate%3DSeptember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00703"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1990</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00703" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Duncan&quot;,&quot;last_name&quot;:&quot;E. Shaw&quot;},{&quot;first_name&quot;:&quot;Ferheen&quot;,&quot;last_name&quot;:&quot;Baig&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Bruce&quot;},{&quot;first_name&quot;:&quot;Sylvie&quot;,&quot;last_name&quot;:&quot;Chamoin&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;P. Collingwood&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Cross&quot;},{&quot;first_name&quot;:&quot;Satish&quot;,&quot;last_name&quot;:&quot;Dayal&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Drückes&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Furet&quot;},{&quot;first_name&quot;:&quot;Vikki&quot;,&quot;last_name&quot;:&quot;Furminger&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Haggart&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Hussey&quot;},{&quot;first_name&quot;:&quot;Irena&quot;,&quot;last_name&quot;:&quot;Konstantinova&quot;},{&quot;first_name&quot;:&quot;Jon&quot;,&quot;last_name&quot;:&quot;C. Loren&quot;},{&quot;first_name&quot;:&quot;Valentina&quot;,&quot;last_name&quot;:&quot;Molteni&quot;},{&quot;first_name&quot;:&quot;Sonia&quot;,&quot;last_name&quot;:&quot;Roberts&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Reilly&quot;},{&quot;first_name&quot;:&quot;Alex&quot;,&quot;last_name&quot;:&quot;M. Saunders&quot;},{&quot;first_name&quot;:&quot;Rowan&quot;,&quot;last_name&quot;:&quot;Stringer&quot;},{&quot;first_name&quot;:&quot;Lilya&quot;,&quot;last_name&quot;:&quot;Sviridenko&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Thomas&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;G. Thomson&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Tomlins&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Vince&quot;,&quot;last_name&quot;:&quot;Yeh&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;C. Pearce&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7901-7914&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00703&quot;},&quot;abstract&quot;:&quot;A series of potent PDGFR inhibitors has been identified. The series was optimized for duration of action in the lung. A novel kinase occupancy assay was used to directly measure target occupancy after i.t. dosing. Compound 25 shows 24 h occupancy of the PDGFR kinase domain, after a single i.t. dose and has efficacy at 0.03 mg/kg, in the rat moncrotaline model of pulmonary arterial hypertension. Examination of PK/PD data from the optimization effort has revealed in vitro:in vivo correlations which link duration of action in vivo with low permeability and high basicity and demonstrate that nonspecific binding to lung tissue increases with lipophilicity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00703&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00703" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00703&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00703" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00703&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00703" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00703&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00703&amp;href=/doi/10.1021/acs.jmedchem.6b00703" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00703" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00703" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00703%26sid%3Dliteratum%253Aachs%26pmid%3D27502700%26genre%3Darticle%26aulast%3DShaw%26date%3D2016%26atitle%3DOptimization%2Bof%2BPlatelet-Derived%2BGrowth%2BFactor%2BReceptor%2B%2528PDGFR%2529%2BInhibitors%2Bfor%2BDuration%2Bof%2BAction%252C%2Bas%2Ban%2BInhaled%2BTherapy%2Bfor%2BLung%2BRemodeling%2Bin%2BPulmonary%2BArterial%2BHypertension%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D17%26spage%3D7901%26epage%3D7914%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291774" title="Nuclear magnetic resonance spectroscopy">Nuclear magnetic resonance spectroscopy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/17" title="Go to Volume 59, Issue 17"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/jmcmar.2016.59.issue-17/20160908/jmcmar.2016.59.issue-17.largecover.jpg" alt="Go to Volume 59, Issue 17"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of potent PDGFR inhibitors has been identified. The series was optimized for duration of action in the lung. A novel kinase occupancy assay was used to directly measure target occupancy after i.t. dosing. Compound <b>25</b> shows 24 h occupancy of the PDGFR kinase domain, after a single i.t. dose and has efficacy at 0.03 mg/kg, in the rat moncrotaline model of pulmonary arterial hypertension. Examination of PK/PD data from the optimization effort has revealed in vitro:in vivo correlations which link duration of action in vivo with low permeability and high basicity and demonstrate that nonspecific binding to lung tissue increases with lipophilicity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pulmonary arterial hypertension (PAH) is a progressive and deadly disease with a poor prognosis despite the introduction of multiple therapeutic classes over the past decade.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The disease is characterized by increases in pulmonary vascular resistance (PVR) such that the resting mean pulmonary arterial pressure rises above 25 mmHg.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The disease is driven by aberrant smooth muscle proliferation in the pulmonary arteries and arterioles which increasingly makes passage of blood more difficult. Characteristic plexiform lesions, which show medial hypertrophy and fibrotic intimal lesions can envelop the entire artery wall, are also features of the pathology. The current marketed therapies function by vasodilation and have limited effects on the progression of the smooth muscle proliferation or on lesion formation.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">The platelet-derived growth factor (PDGF) is a powerful mitogen which signals through the receptor tyrosine kinases (PDGFRα and PDGFRβ). Both the chemokine and its receptor have been shown to be overexpressed in both the pulmonary artery smooth muscle cells (PASMC) and the endothelial cells of severe PAH patients. Actively proliferating PASMC has been shown to have raised levels of phosphorylated PDGFR.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Oral Imatinib <b>1</b> demonstrated efficacy in the first trial to investigate the effects of a nonvasodilatory agent in PAH. The rationale for initiating the clinical trial was the activity of <b>1</b> as an inhibitor of PDGFR receptor tyrosine kinases. The drug targeted the remodeling of the pulmonary arteries and thus attempted to alter the course of the disease. Patients in the trial showed improvements in 6 min walk distance and reduced PVR measured by right heart catheterization.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The systemic administration of <b>1</b> is however associated with side effects, and these led to significant numbers of patients withdrawing from the trial. Indeed in the IMPRES (phase III) trial, despite clear clinical benefits, a positive risk benefit ratio could not be demonstrated.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">It was hypothesized that an inhibitor of PDGFR locally administered by inhalation might achieve efficacy similar or better than <b>1</b> but with greatly reduced systemic side effects.</div><div class="NLM_p">When the desired site of action is in the lung, inhalation can be used to reduce the systemic side effects of a medication. A key challenge to this approach is the rapid absorption of small molecules from the airways into the systemic circulation, since it has been clearly demonstrated that the lung offers little barrier to the absorption of soluble drugs.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The maintenance of duration of action in the lung, such that clinical dosing can be once or twice a day, is a key objective in inhaled drug design.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">The selective inhibition of PDGFR in the lung vasculature presented a challenging objective. While there is extensive precedent for inhaled medicines demonstrating an enhanced therapeutic index, the site of action for these drugs is typically in the airway epithelial tissue (e.g., β2 agonists, M3 antagonists).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The target tissue for this project was the smooth muscle surrounding the pulmonary arteries and arterioles of the lung, and by definition, this tissue is separated by only a short distance from the circulatory system. This presented a novel drug delivery challenge, to achieve sufficient exposure in the target tissue while avoiding rapid equilibration of the drug with the rest of body. Given the novel nature of the drug delivery challenge, the characteristics shown to be desirable for traditional inhaled drugs were not necessarily relevant to this project. The strategy taken was to profile a selection of potent PDGFR inhibitors in an in vivo mechanistic assay to measure duration of action and in parallel to assess an extensive range of in vitro parameters. This data set allowed the establishment of in vitro:in vivo correlations (ivivc) which were then used to prioritize subsequent optimized molecules for in vivo testing.</div><div class="NLM_p">A search for novel chemotypes, which could display similar kinase activity, was initiated, in the Novartis sample collection, based on the cocrystal structure of <b>1</b> with cKit (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=IT46">IT46</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The imidazo[1,2-<i>a</i>]pyridine <b>2</b> (Rat A10 IC<sub>50</sub> 36 ± 16 nM) was identified as a potent inhibitor of PDGFR and cKit. Furthermore, the pyrazolo[1,5-<i>a</i>]pyridine <b>3</b> (Rat A10 IC<sub>50</sub> 12 ± 5 nM) offered an attractive alternative chemotype (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). These molecules compared well to <b>1</b> (Rat A10 IC<sub>50</sub> 162 ± 39 nM) in a cell-based assay of PDGFβ-driven proliferation in rat A10 PASMC and thus offered attractive starting points. Compounds <b>2</b> and <b>3</b> were both identified by separate Novartis project teams in search of novel and patentable analogues of <b>1</b>. They were considered ideal starting points for this work since they maintained a kinase selectivity profile similar to that of <b>1</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead molecules identified from the Novartis sample collection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds described in this paper were synthesized according to the general scheme (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The compounds could be prepared by standard methods in a flexible way using orthogonal chemistry which allowed for a number of interchangeable synthetic routes. Largely commercially available 3-aminobenzoic acids or esters <b>4</b> were used as the core, and amide coupling with fused pyrazolopyridine or imidazopyridine carboxylic acids (optionally substituted with bromine) allowed access to the central intermediates <b>5</b>. The final compounds could then be accessed by carrying out an initial palladium-catalyzed coupling to give <b>6</b>, followed by an amide coupling. Alternatively one can perform an amide coupling reaction to give <b>7</b> and then a palladium-catalyzed cross coupling reaction to give the final products. This chemistry was employed flexibly to enable structural variation at either end of the molecule.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General scheme for preparation of the compounds described. For specific structures of R<sup>1</sup> and R<sup>2</sup> refer to Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and 2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Imidazopyridine 6-Substituent upon Potency, Permeability, and Lipophilicity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0016.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0017.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Inhibition of probe substrate phosphorylation by PDGFRα, measured by capillary electrophoresis. Determinations based on <i>n</i> = 3 or more.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Inhibition of PDGFRβ-driven proliferation of Rat A10 cells. Determinations based on <i>n</i> = >3 or more.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></p></div></div><div></div></div><div class="NLM_p">The pyridine core molecule <b>4c</b> was novel and was synthesized as described in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. Chlorination of the nitro derivative <b>8</b> allowed formation of the chloropyridine with concomitant esterification of the carboxylic acid to furnish <b>9</b>. Hydrogenation of the nitro group then allowed the core amino pyridine <b>4c</b> to be synthesized.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Preparation of the pyridine core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The amine groups used to form R<sup>1</sup> were commercially available with the exception of (5,5-dimethyltetrahydrofuran-2-yl) methanamine <b>11</b>, which was synthesized as shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. The commercially available bromocyclisation product <b>10</b> was converted into the intermediate azide, which was subsequently reduced using triphenylphosphine to give the desired primary amine.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Synthesis of (5,5-dimethyltetrahydrofuran-2-yl) methanamine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PDGFRα inhibition was assessed in a biochemical assay using the isolated kinase domain and examining the degree of phosphorylation of a probe peptide substrate in the presence of the test molecule.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The cell-based activity of the test molecules was determined by measuring the effect of the compound on the PDGFβ-driven proliferation of Rat A10 (PASMC) over a four day period.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> A homology model was generated based on the cKIT cocrystal structure of <b>1</b>,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and this model was used to predict the binding mode of <b>7c</b>. Examination of the predicted docking modes suggested substitution of the imidazopyridine ring of <b>2</b> at the 6-position would be tolerated since space existed at that position (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Indeed a boost in potency was achieved when a range of small heterocycles were incorporated at this position (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The introduction of a 3-pyridyl substituent <b>12</b> gave an increase in cell-based activity. The methyl 5-pyrazolyl <b>13</b> and methyl 3-pyrazolyl <b>14</b> substituents were also particularly beneficial, with reductions in permeability leading to a bigger disconnect between potency in the isolated enzyme system and that seen in the cell-based assay. However, by finding successively more potent inhibitors in the enzyme assay, the desired level of cell-based potency could be maintained, despite the reduced permeability. The 3-pyrazolyl substituent <b>15</b> maintained functional activity at the enzyme but was slightly less potent in the cell-based assay suggesting that the reduction in permeability had begun to impact cell penetration (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking of <b>7c</b> into the homology model generated from the PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a> (<b>1</b> cocrystallized with cKit).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (A) The position of <b>1</b> (cyan) compared to the proposed binding mode for <b>7c</b> (orange). (B) The potential space at the 6-position of the imidazopyridine, by replacement of the bromo substituent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The presence of an aryl piperazine substituent in these molecules was seen as a risk in terms of potential off target activity, since compounds containing this moiety are known to bind promiscuously to GPCRs and ion channels.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Indeed compound <b>13</b> showed an IC<sub>50</sub> of binding <10 μM at 9 out 26 GPCRs tested and exhibited binding at the HERG channel (IC<sub>50</sub> = 4 μM). A search for an alternative amide substituent with a lower lipophilicity and MW was initiated guided by docking studies (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Amide Substituent upon Potency, Permeability, and Lipophilicity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0018.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0019.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Inhibition of probe substrate phosphorylation by PDGFRα, measured by capillary electrophoresis. Determinations based on <i>n</i> = 3 or more.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Inhibition of PDGFRβ-driven proliferation of Rat A10 cells. Determinations based on <i>n</i> = >3 or more.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></p></div></div><div></div></div><div class="NLM_p">The substituted difluorobenzyl compound <b>16</b> showed very high potency indicating that the size of the amide substituent could be reduced without detrimental effects on potency. Compound <b>16</b>, however, showed poor solubility (no detectable solubility in the i.t. dosing vehicle 10% PEG 200/95% D5W), suggesting it would be beneficial to introduce polarity into the molecules. The dimethyltetrahydrofuran <b>17</b>, exhibited potency equivalent to <b>16</b> with reduced lipophilicity. The introduction of a basic amine such as <b>18</b> was also tolerated. An improved understanding of the required elements for optimal lipophilic binding was derived from comparison of compounds <b>19</b> and <b>20</b> in which no further advantage is gained by extension of the aliphatic side chains. This improved understanding led to the discovery of the cyclic derivative <b>21</b>. The potency could be improved further using the methyl 5-pyrazolyl substituent to give <b>22</b>.</div><div class="NLM_p">With the SAR established for both the amide portion and the hinge binding extension, it was considered important to re-examine the alternative core structures. Both the pyrazolopyridine <b>23</b> and the 2-methylpyridine <b>24</b> showed good in vitro potency and allowed the direct comparison to the original imidazo[1, 2-<i>a</i>] pyridine core structure <b>13</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The core changes were well tolerated in terms of potency in vitro and led to modified properties allowing us to examine the effects of such changes on duration of action in vivo (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). The optimal amide and hinge extension substituents identified in the earlier work were then transferred into the 2-methylpyridine core, using the pyrazolopyridine as the hinge binding group; this allowed the identification of <b>25</b>. This compound showed a much improved selectivity profile with respect to binding to GPCRs (26 tested 24 > 30 μM, M1 IC<sub>50</sub> 5.0 μM; H3 IC<sub>50</sub> 5.0 μM) and had an IC<sub>50</sub> > 30 μM at the HERG channel. These data were supportive of further profiling particularly given the low anticipated dose based on the inhaled route of delivery (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>)</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of Changes to the Aniline Core and the 6,5 Heterocycle upon Potency, Permeability, and Lipophilicity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0020.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center" char="±">CE PDGFRα IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">Rat A10 assay IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">PAMPA permeability % transcellular<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">9.2 ± 1.6</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">3.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>23</b></td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">10.3 ± 2.8</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">3.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>24</b></td><td class="colsep0 rowsep0" align="char" char="±">0.96 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">35 ± 12</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">3.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="char" char="±">0.2 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">12.8 ± 0.9</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">2.90</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Inhibition of probe substrate phosphorylation by PDGFRα, measured by capillary electrophoresis. Determinations based on <i>n</i> = 3 or more.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Inhibition of PDGFRβ-driven proliferation of Rat A10 cells. Determinations based on <i>n</i> = >3 or more.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Occupancy of the PDGFR Kinase Domain and Lung Concentrations from in Vivo Studies</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center" char=".">solubility<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> mg/mL</th><th class="colsep0 rowsep0" align="center" char=".">i.t. dose mg/kg</th><th class="colsep0 rowsep0" align="center" char="±">% occ 7 h<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">[lung] at 7 h (nM)</th><th class="colsep0 rowsep0" align="center" char="±">% occ 24 h<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">[lung] at 24 h (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="char" char="."><0.01</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">27 ± 11</td><td class="colsep0 rowsep0" align="char" char="±">276200 ± 143700</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">0.77</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char="±">54 ± 24</td><td class="colsep0 rowsep0" align="char" char="±">188 ± 32</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">0.77</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char="±">70 ± 25</td><td class="colsep0 rowsep0" align="char" char="±">687 ± 188</td><td class="colsep0 rowsep0" align="char" char="±">9 ± 19</td><td class="colsep0 rowsep0" align="char" char="±">60 ± 39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">0.59</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char="±">75 ± 13</td><td class="colsep0 rowsep0" align="char" char="±">302 ± 56</td><td class="colsep0 rowsep0" align="center" char="±">0</td><td class="colsep0 rowsep0" align="char" char="±">44 ± 16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char="±">82 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">1026 ± 255</td><td class="colsep0 rowsep0" align="char" char="±">51 ± 9</td><td class="colsep0 rowsep0" align="char" char="±">420 ± 85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char="±">29 ± 22</td><td class="colsep0 rowsep0" align="char" char="±">221 ± 144</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char="±">83 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">3950 ± 1100</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char="±">88 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">1304 ± 230</td><td class="colsep0 rowsep0" align="char" char="±">81 ± 9</td><td class="colsep0 rowsep0" align="char" char="±">680 ± 121</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">10% PEG200/95% D5W. i.t. dosing vehicle, i.t. dosing of vehicles with higher organic content is not well tolerated.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">As determined by immunoprecipitation from lung tissue lysates using CST4564.</p></div></div></div><div class="NLM_p">The identified compounds were screened in a range of in vitro assays (high-throughput solubility, PAMPA,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> CACO2 (A-B/B-A), CACO2 <i>P</i><sub>app</sub>, RLM CL<sub>int</sub>, CHI-IAM membrane retention,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> RSA binding,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> HSA binding,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a><i>V</i><sub>ss</sub> calcd<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>) and in silico calculations (cLogP, PSA, cLogD) to assess their physicochemical properties (full data set is in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The intention of this exercise was initially to facilitate the development of ivivc rather than to screen out any particular property at this stage. Potent compounds with a range of properties were then screened in vivo by measurement of kinase site occupancy.</div><div class="NLM_p">Critical to the success of this strategy was the identification of a direct method for measurement of duration of action. In this respect the identification of the PDGFR-β antibody CST4564<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> was vital. This antibody has the remarkable property that it can only recognize PDGFR-β in its active form. When the kinase is in an inactive form (i.e., in the presence of a type II kinase inhibitor), the antibody does not recognize PDGFR-β in immunoprecipitation experiments. Applying this finding to ex-vivo tissue from PK–PD experiments allowed us to determine the percentage of the PDGFR-β in the given tissue sample which was bound to compound and, therefore, to directly measure kinase occupancy. Control experiments were able to show that addition of excess test compound to the lysates during the processing and immunoprecipitation work up did not affect the level of PDGFR occupancy measured. This finding confirmed that our readout was directly correlated to the occupancy seen in the in vivo experiment.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">The poorly soluble analogue <b>16</b> was shown to exhibit low occupancy at 7 h after a 1 mg/kg dose, despite very high measured lung levels. This observation indicated that the drug was very likely still in the airway and not absorbed into the lung tissue itself. As a result of this early finding, in vivo testing was confined to molecules which could be shown to have sufficient solubility in the dosing vehicle (10% PEG 200/95% D5W).</div><div class="NLM_p">The dosing of soluble compounds led to much lower apparent lung levels and also led to superior occupancy; compounds <b>13</b> and <b>18</b>, for example, exhibited duration of action to 7 h (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div class="NLM_p">Another key comparison was that between the core structures, with <b>23</b> showing relatively poor duration of action compared to <b>13</b>, the duration of action was recovered when the pyridyl core was introduced in <b>24</b>.</div><div class="NLM_p">The common factor between <b>13</b> and <b>24</b> is that they possess two basic centers at physiological pH which is not the case for <b>23</b>. This suggested that these dibasic compounds had some intrinsic advantage. Additionally the decreased lipophilicity of <b>24</b> is a factor and an improved occupancy was demonstrated despite somewhat lower cell-based activity.</div><div class="NLM_p">The improved amide substituent and the optimal hinge extension, when combined with the more polar core structure <b>25</b> further improved the in vivo profile leading to occupancy of >80% at 24 h after a 0.1 mg/kg dose.</div><div class="NLM_p">For a set of 40 compounds tested in vivo,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> a data set was obtained that enabled assessment of ivivc. The compound set consisted of potent compounds (IC<sub>50</sub> < 50 nM in the rat A10 assay), all of which had good solubility in the dosing vehicle. These restrictions mean that the data set is not well suited to assessing the effect of potency or solubility upon duration of action.</div><div class="NLM_p">As an initial unbiased approach, a random forest plot was generated to show which of the in vitro parameters measured correlated most strongly to occupancy at 8 h and to the concentration of drug required to reach 50% occupancy (Occ<sub>50</sub>) in the in vivo studies (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Random forest comparison of in vivo occupancy to in vitro parameters. (A) Relative correlation strength between occupancy at 8 h and various in vitro measurements. (B) Relative correlation strength between Occ<sub>50</sub> and various in vitro measurements.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When considering occupancy at 8 h, by far the strongest correlation was that seen to permeability in the artificial membrane PAMPA assay (x. transcellular). A correlation was also observed to clearance in rat liver microsomes (CL<sub>int</sub>, RLM.ER), and a role for basicity was identified by correlations seen to cLogD and p<i>K</i><sub>a</sub>. Lipophilicity in isolation was not a good predictor of duration of action, but had by far the strongest correlation to Occ<sub>50</sub>.</div><div class="NLM_p">It was possible to show that permeability, measured in the artificial membrane PAMPA assay, correlated with duration of action (see <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Compounds with good occupancy at 7 h after an i.t. dose were shown to exhibit much lower permeability than those without occupancy at 7 h (<i>p</i> = 0.00003).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Permeability is a key factor in determining duration of action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While low permeability was necessary for duration of action, it was not sufficient, and compounds with low permeability were also shown to lack duration of action in many cases. Absorption of low molecular weight compounds from the airway into the systemic circulation is known to be rapid.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> One can speculate that for soluble compounds, absorption from the airway may be too rapid to allow a significant depoting effect to occur as part of the first pass absorption event. Low permeability may be necessary to slow the absorption and allow the opportunity for depoting to occur in the case where a compound has sufficient affinity for lung tissue.</div><div class="NLM_p">A correlation with high p<i>K</i><sub>a</sub> was observed, with more basic compounds showing a higher tendency to have good duration of action (<i>p</i> = 0.011) (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). This empirical observation is consistent with the known affinity of basic molecules for tissue and in this case could be a representative surrogate measure of lung tissue affinity.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. More basic compounds exhibit longer duration of action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Correlations were also observed within the data, when the amount of drug required to achieve 50% occupancy (Occ<sub>50</sub>) was considered. A clear positive correlation between Occ<sub>50</sub> and cLogP was observed (<i>p</i> = 0.00028) (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>), suggesting a role for nonspecific binding of drug to the tissue. Less lipophilic molecules are likely to be more available to the target due to a reduction in nonspecific tissue binding.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. cLogP correlates with Occ<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Within the set of molecules evaluated, no direct correlations were seen between membrane affinity and occupancy. Furthermore, a close link was observed between PK and PD across the compound set. This link suggests that, for these molecules at least, there is little role for variations in binding kinetics (<i>K</i><sub>on</sub>/<i>K</i><sub>off</sub>), in determining duration of action. Variations in binding kinetics would be expected to manifest themselves in a disconnect between PK and PD.</div><div class="NLM_p">Using column methods, it was possible to estimate a rat volume of distribution based on rat HSA binding and CHI-IAM measurements,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and using this data and measurement of CL<sub>int</sub> from rat liver microsomes, it was possible to estimate an in vivo half-life for the compound set. This estimated number correlated well with duration of action (<i>p</i> = 0.003) (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>) despite being essentially an estimate of systemic clearance, which did not take into account the effects of secondary metabolism, renal or biliary clearance. Interestingly the compounds with the best duration of action (e.g., <b>22</b> and <b>25</b>) were outliers in this analysis, being the compounds with the highest predicted in vivo half-life. Purely by use of in vitro methods, a prediction of duration of action for this compound class can be made. A possible interpretation of this empirical observation is that molecules with high predicted microsomal clearance are also metabolized in the lung tissue itself, leading to a shorter duration of action. Measurements of lung microsomal stability were not carried out for compounds within this series. Interestingly although systemic half-life was predicted to be very long for <b>25</b>, the molecule was primarily cleared by renal excretion of parent and had an in vivo half-life in rat of 14 ± 3 h. This had the effect of reducing systemic exposure without compromising lung levels.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Calculated in vivo half-life correlates with duration of action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The comparison of the occupancy seen with <b>25</b> when dosed by the i.t. and i.v. routes gives a clear indication of the enhanced therapeutic index obtained by the i.t. delivery route, which is a consequence of depoting in the lung tissue as part of the absorption from the airways. The enhanced occupancy seen makes it clear that the depoted compound is also available at the site of action. For a given systemic exposure much more occupancy is achieved by the i.t. route (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>). Compound <b>25</b> showed high bioavailability after i.t. dosing (<i>F</i> = 90%), but a comparison of lung levels by the i.t. and i.v. routes shows that the tissue distribution has been altered with a much higher lung: plasma ratio enabling enhanced lung efficacy to be achieved.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Comparison of occupancy after i.t. and i.v. dosing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm that the occupancy of the PDGFR kinase observed translated into inhibition of downstream signaling, the efficacy of <b>25</b> was assessed in a the monocrotaline (MCT) model of PAH. Pulmonary artery smooth muscle proliferation was measured in rats pretreated with MCT for 2 weeks.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a><b>25</b> was administered twice daily by the i.t. route for 7 days in a therapeutic mode (i.e., pathology was allowed to develop before administration of the test compound). Oral administration of <b>1</b> was used as a positive control in the study, since it has shown efficacy in human clinical trials.</div><div class="NLM_p">Compound <b>25</b> showed antiremodeling efficacy against MCT-induced smooth muscle cell proliferation in the pulmonary vasculature (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>). The minimum efficacious dose of <b>25</b> was 0.03 mg/kg (twice daily), which significantly reduces the percent of fully muscularized vessels to 14.3 (SEM = 1.6%) compared to 34.6 (SEM = 3.1%) in the MCT vehicle control group (A). Imatinib <b>1</b> significantly reduced the muscularization of small vessels at 100 mg/kg (A). However, in a separate experiment, no efficacy was observed when administering <b>1</b> at 25 mg/kg, a dose which provides equivalent exposure to that achieved in patients receiving a 400 mg/day dose of <b>1</b> as part of the PAH Phase III clinical trial (B).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This comparative data suggest that clinical efficacy may be observed at drug exposures which were well below those required for efficacy in the MCT model.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A) Efficacy of <b>25</b> (i.t.) in the rat MCT model of pulmonary hypertension in comparison to <b>1</b> (p.o.), expressed as a percentage of fully muscularised small blood vessels within the lung upon histological evaluation. (B) Efficacy of a clinically relevant dose of <b>1</b> (p.o.) in the rat MCT model of pulmonary hypertension expressed as a percentage of fully muscularised small blood vessels within the lung upon histological evaluation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By using lower doses and i.t. administration of compound, the systemic burden in terms of blood levels is significantly reduced compared to oral administration of <b>1</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Systemic Exposure of Test Compound in the MCT Model</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compd</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="±">blood conc. (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.081</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.75 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.90 ± 0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="±">305.5 ± 268.5</td></tr></tbody></table></div></div><div class="NLM_p">A stable crystalline saccharin salt of <b>25</b> was identified as suitable for micronisation and inhaled delivery as an aerosol. The compound was then administered to rats at 0.79 mg/kg of as a micronized dry powder,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> over 1 h and showed occupancy consistent with that seen after i.t. dosing given the expected delivery efficiency of 10% (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>).</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Occupancy seen after inhaled dosing of <b>25</b> saccharinate salt.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>25</b> showed good selectivity in a receptor panel of 85 assays at Ricerca with no significant activity at 10 μM, confirming an excellent selectivity observed in an in house screening panel of 45 GPCRs and ion channels. A selectivity screen of 451 kinases at DiscoverX revealed 31 interactions a selectivity score <i>S</i>(35) = 0.08. These interactions were as expected in the PDGFR/KIT and SRC families of receptor tyrosine kinases and pleasingly showed a very similar pattern of selectivity to that seen with <b>1</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>).</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Kinome tree plot for <b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have established that efficacy in the whole lung can be achieved, while maintaining an enhanced therapeutic index over systemic delivery. Within our series of soluble, basic molecules, the desired properties for duration of action have been highlighted. Low permeability has been shown to be important for this series of molecules, and the beneficial effect of high p<i>K</i><sub>a</sub> has also been demonstrated. The effect of a highly basic group has been noted before in inhaled drug design<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> as has the presence of a second less basic center,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and this study reconfirms this finding starting from an unbiased analysis of ivivc. The size of this effect has been quantified for this series of molecules. The effect of nonspecific binding to tissues is a clear factor, and the correlation between cLogP and Occ<sub>50</sub> is perhaps unsurprising given that basic molecules already have an affinity for tissues. Combining basicity with high lipophilicity is likely to lead to extensive nonspecific binding to tissue and to limit the percentage of free drug available to achieve occupancy. The wider applicability of these findings to inhaled drug design in general would be supported by direct measurement of PK–PD at other targets and in more diverse chemical space. Corroboration of these findings from the literature does exist, but the importance of directly measuring pharmacodynamics as well as pharmacokinetics when assessing therapeutic index and duration of action has been emphasized by problems encountered within other inhaled drug discovery projects.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Indeed within this series, high drug levels in the lung have been observed for multiple molecules without correspondingly high target occupancy (e.g., <b>16</b>). By measuring the PD in the same animal at the same time point, it can be established that drug present is binding to the target.</div><div class="NLM_p">By using solutions in our i.t. dosing experiments, we have eliminated the effects of solid form and dissolution rate from our measurements of duration of action and have thereby assessed the intrinsic ability of the molecules to depot in lung tissue as part of the first pass absorption. By using a soluble molecule when dosing i.t., we essentially looked at the worst case scenario for duration of action. The inhaled dosing of a solid form will generally allow for increased duration based on dissolution rate factors. The inhalation PK and PD of the lead molecule <b>25</b> as a saccharin salt validates our assumption that the intrinsic depoting properties and duration of action would not be adversely affected by dosing route and solid form factors.</div><div class="NLM_p">This approach has allowed us to identify <b>25</b>, a potent PDGFR antagonist (10-fold more potent than <b>1</b> in cell-based proliferation assays) with a selectivity profile similar to that of <b>1</b>, which shows excellent duration of action after a single low dose in our PK/PD model.</div><div class="NLM_p">Comparison of the same dose delivered by the i.t. and i.v. routes demonstrates clearly the significant perturbation of the drug distribution to lung obtained by changing dosing route. This is coupled with a clear demonstration that the extra drug levels in the lung lead to enhanced occupancy and duration of action (80% at 24 h after i.t. dose vs 10% at 24 h after i.v. dose). This finding predicts a lower absolute dose requirement in the clinic since a far greater proportion of the dose delivered is reaching the target tissue and is delivering occupancy.</div><div class="NLM_p">Importantly, we have shown that the occupancy obtained translates into efficacy in the MCT model of PAH in rat and that the minimum effective dose, 0.03 mg/kg (i.t. /bid.). is significantly reduced compared to the dose of <b>1</b> which is effective in the model 100 mg/kg (p.o./q.d.).</div><div class="NLM_p last">The IMPRESS trial with oral Imatinib successfully demonstrated efficacy in PAH but was hampered by side-effect-driven patient withdrawals. As an inhaled compound, <b>25</b> has the potential to deliver the efficacy in patients with much lower systemic exposure to drug and to allow greater inhibition of the target in the lung without similar tolerability issues. Further characterization of <b>25</b> will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General Conditions</h3><div class="NLM_p">Compounds were confirmed to be of ≥95% purity or greater by LCMS (methods described below). Mass spectra were run on LCMS systems using electrospray ionization, using Waters Acquity UHPLC with SQD mass spectrometer. [M + H]<sup>+</sup> refers to monoisotopic molecular weights. Purity of tested compounds was determined by LCMS 5 min run (Method 1: ACQUITY UHPLC BEH C18, 130 Å, 1.7 μm, 2.1 × 50 mm, temp 50 °C; flow rate 1.0 mL/min, eluents A H<sub>2</sub>O containing 5 mM ammonium hydroxide; B acetonitrile containing 5 mM ammonium hydroxide; gradient 0.06 min 2% B, 2%–98% B in 4.40 min, 0.35 min 98% B). Intermediates were characterized using a 2 min LCMS run (Method 2: Column Waters BEH C18 50 × 2.1 mm, 1.7 μm, temp 50 °C; flow rate 0.8 mL/min, eluents A H<sub>2</sub>O; B MeOH containing 0.1% TFA; gradient 0.2 min 5% B, 5%–95% B in 1.30 min, 0.25 min 95% B). Structural confirmation was by <sup>1</sup>H NMR and <sup>13</sup>C NMR in conjunction with high-resolution mass spectrometry (HRMS). NMR spectra were run on Bruker AVANCE 400 NMR spectrometers using ICON-NMR. Spectra were measured at 298 K and were referenced using the solvent peak. HRMS was measured on an Acquity G2 Xevo QTof machine. Melting points were determined by differential scanning calorimetry.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> <i>N</i>-(2-Fluoro-5-((2-(4-methylpiperazin-1-yl)benzyl)carbamoyl)phenyl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>2</b></h4><div class="NLM_p">Methyl 3-amino-4-fluorobenzote (350 mg, 2 mmol) and imidazo[1,2-<i>a</i>]pyridine-3-carbonyl chloride (411 mg, 2.2 mmol) were combined in pyridine (7.5 mL) and stirred for 16 h. The reaction mixture was diluted with chloroform and washed with water (×2), the organic layer was washed with 1 M HCl, sat. aq. sodium bicarbonate, and then brine, and the organic layer was then dried (MgSO<sub>4</sub>) and evaporated. The residue was triturated with ethyl acetate and <b>5b</b> (448 mg, 1.3 mmol, 65% yield) was obtained as a white solid. <sup>1</sup>H NMR, (<i>d</i><sub>6</sub>-DMSO, 400 mHz) δ 13.14 (1H, br s), 10.31 (1H, s), 9.48 (1H, d), 8.64 (1H, s), 8.28 (1H, m), 7.87 (1H, m), 7.80 (1H, d), 7.57 (1H, m), 7.46 (1H, m), 7.23 (1H, m).</div><div class="NLM_p last"><b>5b</b> (100 mg, 0.319 mmol), (2-(4-methylpiperazin-1-yl)phenyl)methanamine (197 mg, 0.958 mmol), and 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) (133 mg, 0.958 mmol) were combined in THF (3 mL), and the mixture was then heated to 70 °C for 16h. The mixture was evaporated, and the residue then purified by column chromatography on silica eluting with 0–15% Methanol in DCM. The desired fractions were collected, evaporated, and precipitated with ethyl acetate to give as a white solid <b>2</b> (20 mg, 0.319 mmol, 24% yield). Mp = 71.2 °C; LCMS Method 1; Rt 1.85 min; [MH]+ <i>m</i>/<i>z</i> 487.2; purity 95% <sup>1</sup>H NMR, (<i>d</i><sub>6</sub>-DMSO, 400 mHz) δ 10.30 (1H, s), 9.47 (1H, d), 9.01 (1H, t), 8.62 (1H, s), 8.21 (1H, m), 7.86 (1H, m), 7.80 (1H, d), 7.57 (1H, m), 7.50 (2H, m), 7.18 (5H, m), 4.61 (2H, d), 3.18 (3H, s), 3.01 (8H, m). <sup>13</sup>C NMR(CDCl<sub>3</sub>, 100 MHz) 166.0, 158.4, 155.4, 153.0, 150.4, 148.7, 137.1, 132.9, 131.4, 130.1, 129.1, 128.0, 127.9, 126.3, 125.5, 124.2, 121.4, 118.0, 117.7, 115.9, 114.6, 55.0, 55.0, 50.9, 50.9, 44.7, 41.2; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 487.2225. Calcd 486.2257.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> <i>N</i>-(5-(Benzylcarbamoyl)-2-methylphenyl)pyrazolo[1,5-<i>a</i>]pyridine-3-carboxamide <b>3</b></h4><div class="NLM_p">3-Amino-4-methylbenzoic acid <b>4a</b> (423 mg, 2.77 mmol) was dissolved in DCM, and triethylamine (385 μL, 2.77 mmol) and pyrazolo [1, 5-a] pyridine-3-carbonyl chloride (500 mg, 2.77 mmol) were added. The reaction mixture was stirred for 30 min at RT and then was poured into a separation funnel containing water. The organic layer was collected, and the aqueous layer was extracted with DCM (×3). The combined organic layers were dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness. The product was recrystallized in MeOH, and after filtration 4-methyl-3-(pyrazolo [1, 5-a] pyridine-3-carboxamido) benzoic acid <b>5a</b> was obtained (716 mg, 2.4 mmol 87% yield) of pure compound. LCMS Method 1; Rt 0.54 min; [MH]+ <i>m</i>/<i>z</i> 296.1; purity 99% <sup>1</sup>H NMR, (<i>d</i><sub>6</sub>-DMSO, 400 mHz) δ 12.82 (1H, s), 9.69 (1H, s), 8.84 (1H, d), 8.78 (1H, s), 8.22 (1H, d), 7.99 (1H, d), 7.72 (1H, dd), 7.53 (1H, dd), 7.40 (1H, d), 7.21 (1H, dd), 2.32 (3H, s).</div><div class="NLM_p last"><b>5a</b> (42 mg, 0.14 mmol) was dissolved in DMF (1.0 mL) and treated with HATU (58 mg, 0.152 mmol) and triethylamine (59 μL 0.42 mmol). To this solution was added benzyl amine (18 mg, 0.17 mmol). The reaction mixture was stirred at RT overnight and then diluted with water. The aqueous was washed with 0.5 M LiCl, 0.5 M citric acid, and then brine. The organic layer was dried (MgSO<sub>4</sub>), concentrated in vacuo, and then purified by chromatography on silica eluting with 0–100% ethyl acetate in heptane. <b>3</b> (22 mg, 6 mmol, 38% yield) was obtained as a white solid. Mp = 183 °C ; LCMS Method 1; Rt 1.83 min; [MH]+ <i>m</i>/<i>z</i> 385.2; purity 99% <sup>1</sup>H NMR, (<i>d</i><sub>6</sub>-DMSO, 400 mHz) δ 9.74 (1H, s), 9.03 (1H, t), 8.82 (1H, d), 8.76 (1H, s), 8.22 (1H, d), 7.93 (1H, s), 7.87 (1H, m), 7.74 (1H, d), 7.52 (1H, m), 7.39 (1H, d), 7.31 (3H, m), 7.23(1H, m), 7.14 (1H, t), 4.46 (2H, d), 2.31 (3H, s). <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO, 100 MHz) 164.6, 160.1, 140.7, 139.2, 138.7, 131.2, 129.2, 128.5, 127.1, 126.15, 126.12, 125.6, 124.6, 123.4, 117.6, 114.3, 112.9, 105.1, 41.4, 17.0; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 385.1653. Calcd 385.1664.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Methyl 5-Amino-6-methylnicotinate <b>4c</b></h4><div class="NLM_p">To a suspension of 6-methyl-5-nitro-2-oxo-1, 2-dihydropyridine-3-carboxylic acid <b>8</b> (12.5 g, 63.1 mmol) in chlorobenzene (210 mL) was added DMF (2.4 mL, 31.5 mmol), followed by POCl<sub>3</sub> (23.5 mL, 252 mmol). The mixture was heated at 133 °C for 1 h. After cooling to RT, the mixture was concentrated in vacuo. The residue was cooled in an ice bath, treated with MeOH (200 mL, 4944 mmol), and stirred at RT for 16 h. The mixture was concentrated in vacuo, and the residue was partitioned between water (300 mL) and EtOAc (300 mL). The organics were dried (MgSO<sub>4</sub>) and concentrated in vacuo to afford <b>9</b> as a red crystalline solid (11.8 g, 41 mmol, 80% yield); LCMS Method 2; Rt 1.10 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 230.9.</div><div class="NLM_p"><b>6e</b> was prepared from <b>5e</b> in a similar manner to <b>6c</b>. LCMS: Method 2; Rt 0.69 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 377.5. <sup>1</sup>H NMR (400 MHz, DMSO) δ 13.35 (1H, s), 9.89 (1H, s), 9.18 (1H, s), 8.83 (1H, s), 8.78 (1H, s), 8.34 (2H, d), 8.22 (1H, d), 8.07 (1H, s), 7.82 (1H, d), 3.89 (3H, s), 2.56 (3H, s).</div><div class="NLM_p"><b>5e</b> was prepared from <b>4c</b> in a similar manner to <b>5a</b>. LCMS: Method 2; Rt 0.91 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 391.4. <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.01 (1H, s), 9.32 (1H, s), 8.89 (1H, d), 8.83 (1H, s), 8.38 (1H, d), 8.18 (1H, d), 7.71 (1H, d), 3.93 (3H, s), 2.61 (3H, s).</div><div class="NLM_p last"><b>9</b> (6.9 g, 29.9 mmol) was added to a suspension of ammonium formate (18.87 g, 299 mmol) and 10% Pd/C (0.522 g, 0.491 mmol) in MeOH (330 mL), and the mixture was heated at reflux for 3 h. After cooling to RT, the mixture was filtered through Celite and washed through with MeOH. The solvent was removed in vacuo, and the crude product was triturated with EtOAc to give an orange solid. Purification by chromatography on silica eluting with 0–100% EtOAc in isohexane afforded <b>4c</b> (5.9 g, 35.5 mmol, 76% yield). LCMS: Method 2; Rt 0.25 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 166.8. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (1H, s), 7.52 (1H, s), 3.94 (3H, s), 3.76 (2H, brs), 2.49 (3H, s).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> (5, 5-Dimethyltetrahydrofuran-2-yl)methanamine <b>11</b></h4><div class="NLM_p last"><b>10</b> (36 g, 186 mmol) in DMF (300 mL) was treated with solid sodium azide (12.7 g, 196 mmol) and heated at 90 °C for 4 h. The mixture was allowed to cool to RT and partitioned between water (1.5 L) and ether (2 × 500 mL). The ether layer was separated and washed with 0.5 M LiCl (500 mL), dried (MgSO<sub>4</sub>), filtered and evaporated to afford 5-(Azidomethyl)-2, 2-dimethyltetrahydrofuran (22 g, 142 mmol). The product was dissolved in THF (500 mL), treated with Triphenylphosphine (39.0 g, 149 mmol) and stirred for 5 min. Water (50.0 mL) was added and the reaction mixture was heated at 80 °C for 4 h. The mixture was passed through Isolute SCX-2 resin (200g, 0.67 mmol/g) eluting with MeOH(500 mL), DMSO (100 mL), 20% MeOH:DCM (500 mL) and MeOH (500 mL) followed by elution of the product with 7 M ammonia in MeOH (500 mL). The ammonia layer was evaporated to dryness to afford the <b>11</b> (7.95g, 61 mmol, 43% yield) LCMS: Method 2; Rt 063 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 243.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.03–3.95 (1H, m), 2.80 (1H, dd), 2.68 (1H, dd), 2.06–1.94 (1H, m), 1.79–1.63 (3H, m), 1.24 (3H, s), 1.26 (3H, s).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> <i>N</i>-(2-Fluoro-5-((2-(4-methylpiperazin-1-yl)benzyl)carbamoyl)phenyl)-7-(pyridin-3-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>12</b></h4><div class="NLM_p">7-bromoimidazo[1,2-<i>a</i>]pyridine-3-carboxylic acid (1.8 g, 7.47 mmol) and thionyl chloride (10 mL, 137 mmol) were heated at reflux for 1.5 h. The reaction mixture was concentrated in vacuo and azeotroped with toluene. Methyl 3-amino-4-fluorobenzoate (1.263 g, 7.47 mmol) was added, followed by pyridine, and the mixture was stirred at RT overnight. The reaction mixture was diluted with EtOAc and washed with H<sub>2</sub>O. The resulting solid was collected by filtration. The filtrate was dried (MgSO<sub>4</sub>) and concentrated in vacuo and triturated with ether to afford cream solid. The solids were combined and dried at 45 °C to afford <b>5c</b>; LCMS: Method 2; Rt 0.97 min; [MH]+ <i>m</i>/<i>z</i> 392; <sup>1</sup>H NMR (400 MHz, DMSO-d6) δ 10.3 (1H, s), 9.4 (1H, d), 8.6 (1H, s), 8.3 (1H, m), 8.2 (1H, s), 7.9 (1H, m), 7.5 (1H, t), 7.4 (1H, d), 3.9 (3H, s).</div><div class="NLM_p"><b>5c</b> (1.08 g, 2.75 mmol), TBD (0.383 g, 2.75 mmol), and (2-(4-methylpiperazin-1-yl) phenyl) methanamine (0.565 g, 2.75 mmol) in toluene (35 mL) were heated to 80 °C overnight. Toluene was removed in vacuo, and the resulting solid was partitioned between aqueous sodium bicarbonate solution and EtOAc. The organic portion was washed with sodium bicarbonate solution (2 × 50 mL) and concentrated in vacuo. The resulting oil was purified by chromatography on silica eluting with 0–10% MeOH in DCM. The fractions were combined and the solvent removed in vacuo. The resulting solid was recrystallized from EtOAc (50 mL) to afford <b>7c</b> (457 mg, 0.78 mmol, 28% yield); LCMS: Method 2; Rt 0.85 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 567.4 <sup>1</sup>H NMR (400 MHz, d6-DMSO) δ 10.3 (1H, s), 9.4 (1H, d), 8.9 (1H, t), 8.6 (1H, s), 8.2 (1H, d), 8.1 (1H, s), 7.8 (1H, m), 7.4 (1H, d), 7.35 (1H, d), 7.2 (2H, m), 7.1 (1H, d), 7.0 (1H, t), 4.6 (1H, d), 2.9 (4H, m), 2.4 (3H, t), 2.2 (3H, s).</div><div class="NLM_p last">Under nitrogen, <b>7c</b> (120 mg, 0.212 mmol), pyridine-3-ylboronic acid (33.8 mg, 0.212 mmol), triethylamine (0.030 mL, 0.212 mmol), cesium carbonate (69.1 mg, 0.212 mmol), and PdCl<sub>2</sub>(dppf)·CH<sub>2</sub>Cl<sub>2</sub> adduct (17.3 mg, 0.021 mmol) in DMF (3 mL) were heated at 85 °C overnight. The reaction mixture was diluted with EtOAc and water. The organic phase was washed with sat. aq. sodium bicarbonate and brine, then dried (MgSO<sub>4</sub>) and concentrated in vacuo. The crude residue was purified by chromatography on silica eluting with 0–20% MeOH/DCM. To yield <b>12</b> (12 mg 0.21 mmol, 10% yield); Mp = 153.5 °C; LCMS Method 1; Rt 1.89 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 564.2; purity >99% <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.7 (1H, d), 9.1 (1H, d), 8.7 (1H, m), 8.6 (1H, s), 8.4 (1H, m), 8.3 (1H, m), 8.2 (1H, s), 8.1 (1H, s), 7.8 (1H, m), 7.7–7.5 (2H, m), 7.4–7.1 (5H, m), 4.3 (2H, s), 3.1 (4H, m), 2.8 (4H, s broad), 2.5 (3H, t). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 164.5, 158.0, 155.6, 150.0, 149.0, 147.2, 138.7, 135.3, 133.7, 132.8, 132.1, 130.2, 127.2, 127.0, 126.9, 126.0, 125.4, 124.4, 123.4, 122.8, 118.7, 116.9, 115.4, 115.2, 113.7, 112.6, 54.5, 54.5, 51.2, 51.2, 45.0, 37.7; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 564.2512. Calcd 564.2523.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>N</i>-(2-Fluoro-5-((2-(4-methylpiperazin-1-yl)benzyl)carbamoyl)phenyl)-7-(1-methyl-1H-pyrazol-5-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>13</b></h4><div class="NLM_p last">Prepared from <b>7c</b> in a similar manner to <b>8</b> LC-MS: Mp = 244.4 °C; LCMS Method 1; Rt 1.89 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 567.3; purity 98.8% <sup>1</sup>H NMR (400 MHz, MeOD) δ 9.6 (1H, s), 8.6 (1H, s), 8.4 (1H, m), 7.9 (1H, s), 7.8 (1H, m), 7.6 (1H, s), 7.45–7.3 (5H, m), 7.2 (1H, m), 6.7 (1H, s), 4.75 (2H, s), 4.1 (3H, s), 3.4 (4H, s broad), 3.2 (4H, s broad), 2.95 (3H, s). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 164.5, 158.0, 155.6, 150.0, 146.5, 139.4, 138.6, 137.5, 132.8, 130.2, 128.3, 127.0, 126.9, 126.1, 124.4, 124.3, 122.7, 118.7, 117.0, 115.4, 115.2, 115.0, 114.0, 106.4, 54.6, 54.6, 51.3, 51.3, 45.2, 37.7, 37.5; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 567.2618. Calcd 567.2632.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-(2-Fluoro-5-((2-(4-methylpiperazin-1-yl)benzyl)carbamoyl)phenyl)-7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>14</b></h4><div class="NLM_p last">Prepared from <b>7c</b> in a similar manner to <b>8</b> LC-MS: Mp = 189.5 °C; LCMS Method 1; Rt 1.85 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 567.2; purity 97.9% <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ 10.21(1H, s), 9.32 (1H, d), 8.95 (1H, s), 8.57 (1H, s), 8.42 (1H, s), 8.22 (1H, d), 8.13 (1H, s), 7.98 (1H, s), 7.83–7.88 (1H, m), 7.42–7.48 (2H, m), 7.18–7.26 (2H, m), 7.15 (1H, d), 4.58 (2H, d), 3.89 (3H, s), 2.98 (4H, s broad), 2.51 (4H, s broad), 2.26 (3H, s). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 164.4, 158.2, 156.7, 155.6, 148.6, 141.7, 137.6, 137.2, 133.3, 130.3, 130.2, 128.5, 127.5, 127.1, 126.2, 126.0, 123.8, 119.2, 117.7, 117.4, 115.5, 115.3, 115.0, 105.1, 53.4, 53.4 48.4, 48.4 41.5, 38.4, 37.7; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 567.2637. Calcd 567.2632.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-(2-Fluoro-5-((2-(4-methylpiperazin-1-yl)benzyl)carbamoyl)phenyl)-7-(1H-pyrazol-3-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>15</b></h4><div class="NLM_p last">Prepared from <b>25c</b> in a similar manner to <b>8</b>. Mp = 123.8 °C; LCMS Method 1; Rt 1.80 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 553.3; purity >99% <sup>1</sup>H NMR (400 MHz, <i>d</i><sub>6</sub>-DMSO) δ 13.17 (1H, s), 10.26(1H, s), 9.43 (1H, d), 8.98 (1H, t), 8.61 (1H, s), 8.22 (1H, d), 8.15 (1H, s), 7.98 (1H, s), 7.84–7.91 (1H, m), 7.71 (1H, d), 7.45 (1H, t), 7.28–7.22 (2H, m), 7.18–7.02 (3H, m), 4.58 (2H, d), 3.89 (3H, s), 2.84–2.92 (8H, s broad), 2.51 (4H, s broad), 2.25 (3H, s). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 164.5, 158.0, 155.6, 150.1, 147.4, 147.3, 138.5, 132.8, 132.5, 130.2, 129.9, 127.0, 126.9, 126.0, 124.5, 124.4, 122.8, 118.7, 116.9, 115.4, 115.1, 111.5, 111.1, 102.4, 54.5, 54.5, 51.3, 51.3, 45.2, 37.7; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 553.2470. Calcd 553.2476.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-(5-((3,4-Difluorobenzyl)carbamoyl)-2-fluorophenyl)-7-(1-methyl-1H-pyrazol-5-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>16</b></h4><div class="NLM_p last">Prepared from <b>7c</b> in a similar manner to <b>8</b>. Mp = 222.7 °C; LCMS Method 1; Rt 2.00 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 505.2; purity >99% <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.35 (1H, s), 9.50 (1H, d), 9.17 (1H, t), 8.68 (1H, s), 8.19 (1H, d), 8.00 (1H, s), 7.75 (1H, m), 7.56 (1H, s), 7.42–7.50 (3H, m), 7.18 (1H, m), 4.48 (2H, d), 4.01 (3H, s). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 164.4, 158.0, 155.6, 146.6, 139.6, 138.6, 137.5, 129.9, 128.3, 127.0, 126.0, 125.5, 124.4, 123.4, 117.0, 116.8, 116.6, 115.7, 115.5, 115.4, 115.3, 115.1, 114.0, 106.4, 41.3, 37.5; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 505.1598. Calcd 505.1600.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(5-(((5,5-dimethyltetrahydrofuran-2-yl)methyl)carbamoyl)-2-fluorophenyl)-7-(1-methyl-1H-pyrazol-5-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>17</b></h4><div class="NLM_p last">Prepared from <b>7c</b> in a similar manner to <b>8</b> LCMS Method 1; Rt 1.83 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 491.2; purity 95.0% <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.54 (1H, s), 9.53 (1H, d), 8.84 (1H, s), 8.62 (1H, t), 8.17 (1H, dd), 8.09 (1H, s), 7.86–7.81 (1H, m), 7.62–7.42 (3H, m), 6.73 (1H, s), 4.10–4.05 (1H, m), 4.03 (3H, s), 3.37–3.25 (2H, m), 2.06–1.92 (1H, m), 1.78–1.65 (3H, m), 1.22 (3H, s), 1.15 (3H, s) <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 165.3, 158.6, 156.6, 140.3, 138.7, 131.5, 131.4, 128.5, 127.2, 125.2, 125.0, 124.7, 118.4, 116.5, 116.2, 116.0, 114.9, 107.9, 81.0, 77.1, 44.8, 38.7, 38.1, 29.7, 29.6. 28.4; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 491.2228. Calcd 491.2206.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-(5-((2-(2,6-<i>cis</i>-Dimethylpiperidin-1-yl)ethyl)carbamoyl)-2-fluorophenyl)-7-(1-methyl-1H-pyrazol-5-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>18</b></h4><div class="NLM_p last">Prepared from <b>7c</b> in a similar manner to <b>8</b>; Mp = 141.1 °C; LCMS: Method 1; Rt 1.42 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 518.3; purity >99% <sup>1</sup>H NMR (400 MHz, DMSO) δ 10.71 (1H, s), 10.01 (1H, t), 9.72 (1H, d), 9.33 (1H, s), 9.05 (1H, m), 8.90 (1H, s), 8.85 (1H, d), 8.70 (1H, m), 8.47 (1H, s), 8.23 (1H, m), 7.89 (3H, m), 7.51 (1H, m), 3.55 (2H, m), 3.50–3.33 (2H, m), 1.83 (1H, m), 1.70 (2H, m), 1.50 (2H, m), 1.40 and 1.30 (6H, 2<i>d</i>). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 164.7, 158.6, 158.3, 147.2, 140.2, 139.2, 138.1, 130.9, 128.9, 127.6, 126.4, 125.9, 124.9, 117.7, 115.8, 114.6, 107.0, 55.9, 55.9, 47.5, 38.1, 37.0, 34..4, 34.4, 24.2. 21.3, 21.3; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 518.2674. Calcd 518.2680.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-(5-((2-(<i>tert</i>-Butyl(methyl)amino)ethyl)carbamoyl)-2-fluorophenyl)-7-(1-methyl-1H-pyrazol-5-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide. Hydrochloride Salt <b>19</b></h4><div class="NLM_p"><b>5c</b> (1.5 g, 3.82 mmol), 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (0.836 g, 4.02 mmol), Cs<sub>2</sub>CO<sub>3</sub> (4.98 g, 15.30 mmol), and PdCl<sub>2</sub>(dppf)·DCM adduct (0.156 g, 0.191 mmol) were combined in DME (12 mL) and water (5 mL). The mixture was degassed thoroughly refilling with nitrogen (×3). The mixture was stirred at 100 °C for 6 h in the microwave. The reaction mixture was diluted with EtOAc and water, and the resulting product which precipitated out was collected by filtration. The organic phase was washed with sat. NaHCO<sub>3</sub>, brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude residue was combined with the precipitated product and purified by chromatography on silica eluting with 0–10% MeOH/DCM. <b>6a</b> (1g, 2.54 mmol, 66% yield) was obtained.</div><div class="NLM_p"><b>6a</b> (650 mg, 1.6 mmol) in methanol (40 mL) and DCM (10 mL) was treated with sodium hydroxide (132.1 mg, 3.2 mmol) and warmed to 80 °C overnight. The reaction was cooled to RT, and 1 M HCl in methanol was added in excess. The cold mixture was filtered, and then the solvent was removed in vacuo to give <b>6b</b> as the hydrochloride salt (600 mg, 1.58 mmol, 96% yield).</div><div class="NLM_p last"><b>6b</b> (120 mg, 0.289 mmol) and 2-(<i>tert</i>-butyl(methyl)amino)ethanaminium 2,2,2-trifluoroacetate (71 mg 0.289 mmol) were combined in DMF (5 mL) and treated with disopropylethylamine (0.353 mL, 2.020 mmol) and then HATU (115 mg, 0.303 mmol) at 25 °C for 16 h. The residue was partitioned between ethyl acetate and water, and then the aqueous was back extracted with ethyl acetate. The combined organics were washed with 0.5 M LiCl and then brine, and the combined organic layers were dried (MgSO<sub>4</sub>), filtered, and evaporated to dryness (90 mg). The residue was purified by column chromatography eluting with 0–10% MeOH (containing 2 M ammonia) in DCM. The desired fractions were evaporated to dryness and then were suspended in ethanol and treated with 4 M HCl in dioxane before evaporating to dryness; azeotroping with ethyl acetate and ethanol to give <b>19</b> (35 mg, 0.066 mmol, 23% yield). LCMS Method 1; Rt. 1.78 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 492.3; purity 95% <sup>1</sup>H NMR (400 mHz, <i>d</i><sub>6</sub>-DMSO) δ 10.40 (1H, s), 9.50 (1H, d), 9.35 (1H, m), 8.90 (1H, m), 8.73 (1H, m), 8.25 (1H, d), 8.05 (1H, s), 7.86 (1H, m), 7.57 (1H, s), 7.52–7.40 (2H, m), 6.7 (1H, s), 4.05 (3H, s), 3.55 (2H, m), 3.05 (2H, m), 2.80 (3H, s), 1.35 (9H, s). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 163.1, 157.0, 156.2, 154.5, 137.8, 136.4, 128.3, 126.3, 125.0, 122.9, 114.3, 113.9, 112.0, 105.6, 61.3, 48.5, 36.3, 33.2, 32.8, 21.7. 21.7, 21.7; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 492.2536. Calcd 492.2523.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(5-((2-(<i>tert</i>-Butyl(ethyl)amino)ethyl)carbamoyl)-2-fluorophenyl)-7-(1-methyl-1H-pyrazol-5-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>20</b></h4><div class="NLM_p last">Prepared from <b>6b</b> in a similar manner to <b>19</b>. LCMS Method 1; Rt 2.14 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 506.3; purity 95%. <sup>1</sup>H NMR (400 mHz, <i>d</i><sub>6</sub>-DMSO) δ 1.37 (12H, m), 10.50 (1H, s). 9.60 (1H, d), 9.40 (1H, m), 9.10 (1H, m), 8.80 (1H, m), 8.25 (1H, d), 8.07 (1H, s), 7.90 (1H, m), 7.57 (1H, s), 7.51(2H, m), 6.73 (1H, s), 4.05 (3H, s), 3.75 (2H, m), 3.47 (2H, m), 3.15 (2H, m). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 165.5, 159.3, 158.5, 156.9, 140.1, 138.7, 131.6, 130.6, 128.7, 127.2, 126.5, 125.4, 125.3, 116.7, 116.5, 116.4, 114.3, 108.0, 65.4, 49.2, 46.3, 38.7, 37.4, 24.5, 24.5, 24.5, 11.3; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 506.2675. Calcd 506.2680.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(5-((2-(2,2-Dimethylpyrrolidin-1-yl)ethyl)carbamoyl)-2-fluorophenyl)-7-(1-methyl-1H-pyrazol-5-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>21</b></h4><div class="NLM_p last">Prepared from <b>6b</b> in a similar manner to <b>19</b>. LCMS Method 1; Rt 2.00 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 504.3; purity 95.1% <sup>1</sup>H NMR (400 mHz, <i>d</i><sub>6</sub>-DMSO) δ. 10.50 (1H, s), 9.90 (1H, m), 9.40 (1H, d), 8.95 (1H, m), 8.78 (1H, m), 8.24 (1H, d), 8.04 (1H, s), 7.90 (1H, m), 7.57 (1H, s), 7.49 (2H, m), 6.71 (1H, s), 4.05 (3H, s), 3.70 (2H, m), 3.57 (1H, m), 3.25 (1H, m), 3.15 (1H, m), 1.95 (4H, m), 1.20 (6H, m), 3.35 (1H, m). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 165.5, 159.3, 158.7, 156.8, 140.3, 138.7, 130.7, 128.5, 127.3, 126.7, 125.4, 125.2, 118.4, 116.6, 116.4, 116.0, 114.9, 107.8, 59.3, 50.8, 47.7, 38.7, 37.2, 36.0, 22.9, 19.9, 19.8; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 504.2522. Calcd 504.2523.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(5-((2-(2,2-Dimethylpyrrolidin-1-yl)ethyl)carbamoyl)-2-fluorophenyl)-7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-<i>a</i>]pyridine-3-carboxamide <b>22</b></h4><div class="NLM_p">A mixture comprising <b>5c</b> (5.4 g, 13.8 mmol), 1-methyl-1H-pyrazol-4-ylboronic acid (1.9 g, 15.2 mmol), Pd(dppf)Cl<sub>2</sub>.DCM (1.1 g, 1.379 mmol), and cesium carbonate (13.5 g, 41.4 mmol) in DME (100 mL) and water (10 mL) was heated at 100 °C for 4 h. Sodium carbonate (8.9 g, 84 mmol) was added, and the reaction was heated at 100 °C overnight. The reaction mixture was cooled to 50 °C and filtered through glass fiber filter paper. The filtrate was acidified to pH 3 and allowed to cool to RT. A brown precipitate formed which was collected by vacuum filtration and dried at 45 °C to afford <b>6c</b> (5g, 13 mmol, 95%); LCMS: Method 2; Rt 0.68 min; <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 380/381.</div><div class="NLM_p last"><b>6c</b> (6.31 g, 16.63 mmol), 2-(2,2-dimethylpyrrolidin-1-yl)ethanamine (2.84 g, 19.96 mmol), and triethylamine (6.96 mL, 49.9 mmol) in DMF (36.9 mL) and EtOAc (2 mL) was treated dropwise with propylphosphonic anhydride (T3P) (50% w/w in EtOAc) (15.88 g, 24.95 mmol). The resulting mixture was stirred at RT for 16 h and diluted with 10% MeOH/EtOAc (62.7 mL). The mixture was washed with 0.5 M LiCl, H<sub>2</sub>O and sat. aq. NaHCO<sub>3</sub>. The aqueous layer was back-extracted with 10% MeOH: EtOAc (3 × 100 mL). The combined organic extracts was dried MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting solid was triturated with EtOAc and dried at 45 °C. Further purification was carried out by loading the product onto two prewashed 10g Isolute SCX-2 columns and washing through with MeOH. The product was eluted with 2N NH<sub>3</sub> in MeOH to afford a brown solid which was triturated with EtOAc to afford <b>22</b> (3.0 g, 6 mmol, 36%); Mp = 131.3 °C; LCMS Method 1; Rt 1.93 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 504.3; purity 99%; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.4 (1H, d), 8.45 (1H, s), 8.3 (1H, m), 8.2 (1H, s), 8.0 (1H, s), 7.85 (1H, s), 7.8 (1H, m), 7.4 (1H, m), 7.3 (1H, t), 4.0 (3H, s), 3.5 (2H, m), 2.9 (2H, t), 2.7 (2H, t), 1.8 (2H, m), 1.7 (2H, m), 1.0 (6H, s). <sup>13</sup>C NMR (<i>d</i><sub>6</sub>-DMSO, 100 MHz) 164.6, 158.2, 155.7, 147.7, 138.4, 136.4, 129.6, 126.7, 126.1, 125.3, 124.6, 119.1, 117.0, 116.6, 115.4, 112.0, 110.0, 68.44, 49.8, 46.9, 38.2, 36.1, 35.0, 21.9, 18.8, 18.7; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 504.2520. Calcd 504.2523.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(2-Fluoro-5-(2-(4-methylpiperazin-1-yl)benzylcarbamoyl)phenyl)-6-(1-methyl-1H-pyrazol-5-yl)pyrazolo[1,5-<i>a</i>]pyridine-3-carboxamide <b>23</b></h4><div class="NLM_p last">Prepared from <b>7d</b> in a similar manner to <b>8</b>. LCMS Method 1; Rt 1.91 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 553.2; purity >99%. <sup>1</sup>H NMR (400 MHz, DMSO-d6) δ 10.0 (1H, s), 9.9 (1H, m), 9.1 (1H, s), 9.0 (1H, t), 8.9 (1H, s), 8.3 (2H, m), 7.8 (1H, m), 7.7 (1H, d), 7.55 (1H, s), 7.4 (1H, t), 7.3 (2H, m), 7.2 (2H, m), 6.6 (1H, s), 4.6 (2H, d), 4.0 (3H, s), 3.6–3.0 (8H, m), 2.9 (3H, d).<sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 165.7, 161.4, 158.9, 156.4, 150.5, 143.3, 140.0, 138.8, 138.6, 134.1, 131.2, 129.0, 128.7, 128.3, 128.0, 126.1, 126.0, 124.3, 120.0, 119.0, 117.8, 116.3, 107.4, 106.6, 54.8, 54.8, 51.2, 51.2, 46.6, 39.3, 38.0; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 567.2643. Calcd 567.2632.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-(1-Methyl-1H-pyrazol-5-yl)-<i>N</i>-(2-methyl-5-(2-(4-methylpiperazin-1-yl)benzylcarbamoyl)-3-yl)pyrazolo[1,5-<i>a</i>]pyridine-3-carboxamide <b>24</b></h4><div class="NLM_p last">Prepared from <b>6d</b> in a similar manner to <b>19</b> as a hydrochloride salt. LCMS Method 1; Rt 1.71 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 564.3; purity >99%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.76–10.49 (1H, m), 10.16–10.05 (1H, m), 9.19 (1H, m), 9.13 (1H, m), 8.93 (1H, s), 8.89 (1H, s), 8.37 (1H, m), 8.29 (1H, d), 7.71 (1H, dd), 7.54 (1H, 2), 7.34–7.14 (4H, m), 6.59 (1H, d), 4.62 (2H, d), 3.94 (3H, s), 3.49–3.12 (8H, m), 2.84 (3H, d), 2.57(3H, s). <sup>13</sup>C NMR(<i>d</i><sub>6</sub>-DMSO, 100 MHz) 163.0, 159.5, 154.8, 147.6, 142.8, 141.2, 137.8, 136.7, 136.4, 132.2, 130.9, 130.5, 126.9, 126.6, 126.3, 126.2, 122.8, 122.6, 118.2, 116.9, 115.7, 105.3, 104.6, 51.4, 51.4, 47.5, 47.5, 40.5, 36.6, 35.9, 19.6; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 567.2643. Calcd 564.2835.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(5-(2-(2,2-Dimethylpyrrolidin-1-yl)ethylcarbamoyl)-2-methylpyridin-3-yl)-6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyridine-3-carboxamide <b>25</b></h4><div class="NLM_p last">Prepared from <b>6e</b> in a similar manner to <b>19</b> as the hydrochloride salt. Mp = 173 °C. LCMS Method 1; Rt 1.73 min; [MH]<sup>+</sup><i>m</i>/<i>z</i> 501.3; purity >98.2% <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.75 (1H, s), 9.15 (1H, s), 8.75 (2H, m), 8.58 (1H, t), 8.32 (1H, s), 8.25 (1H, s), 8.21 (1H, d), 8.07 (1H, s), 7.82 (1H, d), 3.89 (3H, s), 3.34 (4H, m), 2.76 (2H, t), 2.56 (3H, s), 1.69 (2H, m), 1.53 (2H, m) 0.92 (6H, s). <sup>13</sup>C NMR(MeOH-D4), 100 MHz) 164.7, 163.4, 153.7, 143.7, 140.9, 139.5, 139.3, 137.6, 137.5, 131.7, 129.8, 128.4, 125.9, 122.3, 120.0, 119.5, 106.5, 71.5, 52.3, 48.6, 39.4, 38.4, 37.4, 23.6, 20.6, 20.2, 18.5; HRMS (ESI): <i>m</i>/<i>z</i> (MH<sup>+</sup>) 567.2720. Calcd 501.2726.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00703">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00703" class="ext-link">10.1021/acs.jmedchem.6b00703</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures for cell-based assay/occupancy assay; statistical test details (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">In vitro:in vivo correlation data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf">jm6b00703_si_001.pdf (132.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_002.csv">jm6b00703_si_002.csv (5.81 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_003.csv">jm6b00703_si_003.csv (1.5 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00703" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duncan E. Shaw</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c9adbca7aaa8a7e7baa1a8be89a7a6bfa8bbbda0bae7aaa6a4"><span class="__cf_email__" data-cfemail="5135243f32303f7f22393026113f3e2730232538227f323e3c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ferheen Baig</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Bruce</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvie Chamoin</span> - <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen P. Collingwood</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Cross</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satish Dayal</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Drückes</span> - <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Furet</span> - <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vikki Furminger</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Haggart</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Hussey</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irena Konstantinova</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jon C. Loren</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valentina Molteni</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonia Roberts</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Reilly</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alex M. Saunders</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rowan Stringer</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lilya Sviridenko</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Thomas</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher G. Thomson</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Tomlins</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Wen</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vince Yeh</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew C. Pearce</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes of Biomedical Research (NIBR), 100 Technology Square, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Metabolism and Pharmacokinetics, §Global Discovery Chemistry, and #Respiratory Diseases, NIBR Horsham, Wimblehurst
Road, Horsham, West Sussex RH12 5AB, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">NIBR, Basel Fabrikstrasse 2, 4056 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, California 92121, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>I.K., C.T., and A.P. were responsible for the development and execution of the PD model. F.B. and R.S. were responsible for the accompanying PK data.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare the following competing financial interest(s): All authors are or were employees of Novartis.<br /></br></p></li></ul></div><div class="ack" id="ACK-d257e2837-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27248" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27248" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge Caroline Marshall and Dean Moreton for performing inhalation powder delivery, Danuta Lubika for DSC melting point determinations, Benjamin Lowe for molecular modelling support, and Kerry O’Hare for CHI-IAM, RSA, and HSA determination.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> Abbreviations Used</h2><tr><td class="NLM_term">CACO2</td><td class="NLM_def"><p class="first last">human colon carcinoma cell</p></td></tr><tr><td class="NLM_term">CHI-IAM</td><td class="NLM_def"><p class="first last">chromatographic hydrophobicity index obtained from artificial immobilized membrane</p></td></tr><tr><td class="NLM_term">cKIT</td><td class="NLM_def"><p class="first last">CD117 receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">D5W</td><td class="NLM_def"><p class="first last">5% dextrose in water</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">ivivc</td><td class="NLM_def"><p class="first last">in vitro:in vivo correlation</p></td></tr><tr><td class="NLM_term">MCT</td><td class="NLM_def"><p class="first last">monocrotaline</p></td></tr><tr><td class="NLM_term">PAH</td><td class="NLM_def"><p class="first last">pulmonary arterial hypertension</p></td></tr><tr><td class="NLM_term">PASMC</td><td class="NLM_def"><p class="first last">pulmonary arterial smooth muscle cells</p></td></tr><tr><td class="NLM_term">PDGF</td><td class="NLM_def"><p class="first last">platelet-derived growth factor</p></td></tr><tr><td class="NLM_term">PDGFR</td><td class="NLM_def"><p class="first last">platelet-derived growth factor receptor</p></td></tr><tr><td class="NLM_term">PVR</td><td class="NLM_def"><p class="first last">pulmonary vascular resistance</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">RSA</td><td class="NLM_def"><p class="first last">rat serum albumin</p></td></tr><tr><td class="NLM_term">SRC</td><td class="NLM_def"><p class="first last">sarcoma receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term">SQD</td><td class="NLM_def"><p class="first last">single quadrupole detection</p></td></tr><tr><td class="NLM_term">TBD</td><td class="NLM_def"><p class="first last">1,5,7-triazabicyclo[4.4.0]dec-5-ene</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ghofrani, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, S.</span><span> </span><span class="NLM_article-title">Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1201</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.106.674002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1161%2FCIRCULATIONAHA.106.674002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=18779455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A280%3ADC%252BD1crptFemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1195-1201&author=H.+A.+Ghofraniauthor=M.+W.+Wilkinsauthor=S.+Rich&title=Uncertainties+in+the+diagnosis+and+treatment+of+pulmonary+arterial+hypertension&doi=10.1161%2FCIRCULATIONAHA.106.674002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension</span></div><div class="casAuthors">Ghofrani Hossein A; Wilkins Martin W; Rich Stuart</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1195-201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The availability of new treatments for patients with pulmonary arterial hypertension has increased awareness and interest in the medical community for pulmonary vascular diseases in general.  Many uncertainties exist, however, regarding the diagnosis and treatment of patients with pulmonary arterial hypertension that are particularly pertinent for the management of patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with underlying diseases.  This review highlights controversial issues around the definition and diagnosis of pulmonary hypertension, the interpretation of hemodynamic variables, and the interpretation of clinical responsiveness to chronic therapies.  In addition, we propose guidelines applicable to the conduct of new therapeutic trials in pulmonary arterial hypertension, which aim to provide greater confidence in the efficacy and safety of new treatments currently under development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThl754TC7ldhe4jJGKT5N0fW6udTcc2ea_CGy0_T4Gm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crptFemsw%253D%253D&md5=5fc87373034ef4b670278b14afcbe8c7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.106.674002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.106.674002%26sid%3Dliteratum%253Aachs%26aulast%3DGhofrani%26aufirst%3DH.%2BA.%26aulast%3DWilkins%26aufirst%3DM.%2BW.%26aulast%3DRich%26aufirst%3DS.%26atitle%3DUncertainties%2520in%2520the%2520diagnosis%2520and%2520treatment%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DCirculation%26date%3D2008%26volume%3D118%26spage%3D1195%26epage%3D1201%26doi%3D10.1161%2FCIRCULATIONAHA.106.674002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Badesch, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champion, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez Sanchez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeper, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loyd, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGoon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeige, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olschewski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudiz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torbicki, A.</span><span> </span><span class="NLM_article-title">Diagnosis and assessment of pulmonary arterial hypertension</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">S55</span><span class="NLM_x">–</span> <span class="NLM_lpage">S66</span><span class="refDoi"> DOI: 10.1016/j.jacc.2009.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1016%2Fj.jacc.2009.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=19555859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A280%3ADC%252BD1MvntVKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=S55-S66&author=D.+B.+Badeschauthor=H.+C.+Championauthor=M.+A.+Gomez+Sanchezauthor=M.+M.+Hoeperauthor=J.+E.+Loydauthor=A.+Manesauthor=M.+McGoonauthor=R.+Naeigeauthor=H.+Olschewskiauthor=R.+J.+Oudizauthor=A.+Torbicki&title=Diagnosis+and+assessment+of+pulmonary+arterial+hypertension&doi=10.1016%2Fj.jacc.2009.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis and assessment of pulmonary arterial hypertension</span></div><div class="casAuthors">Badesch David B; Champion Hunter C; Sanchez Miguel Angel Gomez; Hoeper Marius M; Loyd James E; Manes Alessandra; McGoon Michael; Naeije Robert; Olschewski Horst; Oudiz Ronald J; Torbicki Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1 Suppl</span>),
    <span class="NLM_cas:pages">S55-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The diagnosis and assessment of pulmonary arterial hypertension is a rapidly evolving area, with changes occurring in the definition of the disease, screening and diagnostic techniques, and staging and follow-up assessment.  The definition of pulmonary hypertension has been simplified, and is now based on currently available evidence.  There has been substantial progress in advancing the imaging techniques and biomarkers used to screen patients for the disease and to follow up their response to therapy.  The importance of accurate assessment of right ventricular function in following up the clinical course and response to therapy is more fully appreciated.  As new therapies are developed for pulmonary arterial hypertension, screening, prompt diagnosis, and accurate assessment of disease severity become increasingly important.  A clear definition of pulmonary hypertension and the development of a rational approach to diagnostic assessment and follow-up using both conventional and new tools will be essential to deriving maximal benefit from our expanding therapeutic armamentarium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4QCMD4aslbVVwdslNBF-tfW6udTcc2ea_CGy0_T4Gm7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvntVKiug%253D%253D&md5=a66a2ca93dad4e304ba226bf525e4b01</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2009.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2009.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBadesch%26aufirst%3DD.%2BB.%26aulast%3DChampion%26aufirst%3DH.%2BC.%26aulast%3DGomez%2BSanchez%26aufirst%3DM.%2BA.%26aulast%3DHoeper%26aufirst%3DM.%2BM.%26aulast%3DLoyd%26aufirst%3DJ.%2BE.%26aulast%3DManes%26aufirst%3DA.%26aulast%3DMcGoon%26aufirst%3DM.%26aulast%3DNaeige%26aufirst%3DR.%26aulast%3DOlschewski%26aufirst%3DH.%26aulast%3DOudiz%26aufirst%3DR.%2BJ.%26aulast%3DTorbicki%26aufirst%3DA.%26atitle%3DDiagnosis%2520and%2520assessment%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2009%26volume%3D54%26spage%3DS55%26epage%3DS66%26doi%3D10.1016%2Fj.jacc.2009.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Corris, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degano, B.</span><span> </span><span class="NLM_article-title">Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation</span> <span class="citation_source-journal">Eur. Respir. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1183/09059180.00007214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1183%2F09059180.00007214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=25445947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A280%3ADC%252BC2MvmsFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=488-497&author=P.+Corrisauthor=B.+Degano&title=Severe+pulmonary+arterial+hypertension%3A+treatment+options+and+the+bridge+to+transplantation&doi=10.1183%2F09059180.00007214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation</span></div><div class="casAuthors">Corris Paul; Degano Bruno</div><div class="citationInfo"><span class="NLM_cas:title">European respiratory review : an official journal of the European Respiratory Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">134</span>),
    <span class="NLM_cas:pages">488-97</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pulmonary arterial hypertension (PAH) is a rare disease leading to right heart failure and death.  Prognosis remains poor, particularly for patients with severe disease, i.e.  World Health Organization functional class IV.  There have been significant improvements in treatment options.  Several agents are available that target the three main established PAH disease pathways, and can be combined sequentially or upfront.  Strong scientific evidence supports the use of intravenous epoprostenol in severe PAH; however, despite recommendations, many patients do not receive parenteral prostanoids and there is a lack of evidence from randomised clinical trials supporting the value of other PAH medications alone in severe PAH.  Lung transplantation is an important option in patients with severe PAH who have not responded sufficiently to therapy, or who have worsened despite maximal treatment.  Bridging techniques are available for patients who worsen while awaiting transplantation.  The type of bridging technique used depends on various factors including patient illness severity, physician experience and the anticipated waiting time for transplantation.  With the aim to facilitate the treatment decision-making process, herein we review the medical treatment options available for patients with severe PAH, and the bridging techniques that may be used to sustain patients awaiting transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwGj4Y4FSPb691pGlMMoT5fW6udTcc2eaqjIh3mkuiObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvmsFGgsQ%253D%253D&md5=fde8681955f93d9ea36c2d7d4e91e7e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1183%2F09059180.00007214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09059180.00007214%26sid%3Dliteratum%253Aachs%26aulast%3DCorris%26aufirst%3DP.%26aulast%3DDegano%26aufirst%3DB.%26atitle%3DSevere%2520pulmonary%2520arterial%2520hypertension%253A%2520treatment%2520options%2520and%2520the%2520bridge%2520to%2520transplantation%26jtitle%3DEur.%2520Respir.%2520Rev.%26date%3D2014%26volume%3D23%26spage%3D488%26epage%3D497%26doi%3D10.1183%2F09059180.00007214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Perros, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorfmuller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand-Gasselin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tcherakian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pavec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazmanian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mussot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hervé, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emilie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddahibi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonneau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humbert, M.</span><span> </span><span class="NLM_article-title">Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1164/rccm.200707-1037OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1164%2Frccm.200707-1037OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=18420966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVWhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2008&pages=81-88&author=F.+Perrosauthor=D.+Montaniauthor=P.+Dorfmullerauthor=I.+Durand-Gasselinauthor=C.+Tcherakianauthor=J.+Le+Pavecauthor=M.+Mazmanianauthor=E.+Fadelauthor=S.+Mussotauthor=O.+Mercierauthor=P.+Herv%C3%A9author=D.+Emilieauthor=S.+Eddahibiauthor=G.+Simonneauauthor=R.+Souzaauthor=M.+Humbert&title=Platelet-derived+growth+factor+expression+and+function+in+idiopathic+pulmonary+arterial+hypertension&doi=10.1164%2Frccm.200707-1037OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension</span></div><div class="casAuthors">Perros, Frederic; Montani, David; Dorfmuller, Peter; Durand-Gasselin, Ingrid; Tcherakian, Colas; Le Pavec, Jerome; Mazmanian, Michel; Fadel, Elie; Mussot, Sacha; Mercier, Olaf; Herve, Philippe; Emilie, Dominique; Eddahibi, Saadia; Simonneau, Gerald; Souza, Rogerio; Humbert, Marc</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Platelet-derived growth factor (PDGF) promotes the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs), and may play a role in the progression of pulmonary arterial hypertension (PAH), a condition characterized by proliferation of PASMCs resulting in the obstruction of small pulmonary arteries.  Objectives: To analyze the expression and pathogenic role of PDGF in idiopathic PAH.  Methods: PDGF and PDGF receptor mRNA expression was studied by real-time reverse transcription-polymerase chain reaction performed on laser capture microdissected pulmonary arteries from patients undergoing lung transplantation for idiopathic PAH.  Immunohistochem. was used to localize PDGF, PDGF receptors, and phosphorylated PDCFR-β.  The effects of imatinib on PDGF-B-induced proliferation and chemotaxis were tested on human PASMCs.  Measurements and Main Results: PDGF-A, PDGF-B, PDGFR-α, and PDGFR-β mRNA expression was increased in small pulmonary arteries from patients displaying idiopathic PAH, as compared with control subjects.  Western blot anal. revealed a significant increase in protein expression of PDGFR-β in PAH lungs, as compared with control lungs.  In small remodeled pulmonary arteries, PDGF-A and PDGF-B mainly localized to PASMCs and endothelial cells (perivascular inflammatory infiltrates, when present, showed intensive staining), PDGFR-α and PDGFR-β mainly stained PASMCs and to a lesser extent endothelial cells.  Proliferating pulmonary vascular lesions stained phosphorylated PDGFR-β.  PDGF-BB-induced proliferation and migration of PASMCs were inhibited by imatinib.  This effect was not due to PASMC apoptosis.  Conclusions: PDGF may play an important role in human PAH.  Novel therapeutic strategies targeting the PDGF pathway should be tested in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQCTbvHzgVHLVg90H21EOLACvtfcHk0li2tS2yEs8hzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVWhtL0%253D&md5=93f37eb00a8c726fd9381c8aa67117b3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1164%2Frccm.200707-1037OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200707-1037OC%26sid%3Dliteratum%253Aachs%26aulast%3DPerros%26aufirst%3DF.%26aulast%3DMontani%26aufirst%3DD.%26aulast%3DDorfmuller%26aufirst%3DP.%26aulast%3DDurand-Gasselin%26aufirst%3DI.%26aulast%3DTcherakian%26aufirst%3DC.%26aulast%3DLe%2BPavec%26aufirst%3DJ.%26aulast%3DMazmanian%26aufirst%3DM.%26aulast%3DFadel%26aufirst%3DE.%26aulast%3DMussot%26aufirst%3DS.%26aulast%3DMercier%26aufirst%3DO.%26aulast%3DHerv%25C3%25A9%26aufirst%3DP.%26aulast%3DEmilie%26aufirst%3DD.%26aulast%3DEddahibi%26aufirst%3DS.%26aulast%3DSimonneau%26aufirst%3DG.%26aulast%3DSouza%26aufirst%3DR.%26aulast%3DHumbert%26aufirst%3DM.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520expression%2520and%2520function%2520in%2520idiopathic%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2008%26volume%3D178%26spage%3D81%26epage%3D88%26doi%3D10.1164%2Frccm.200707-1037OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ghofrani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrell, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeper, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olschewski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barst, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golpon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toshner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimminger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascoe, S.</span><span> </span><span class="NLM_article-title">Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1177</span><span class="refDoi"> DOI: 10.1164/rccm.201001-0123OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1164%2Frccm.201001-0123OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=20581169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFyhurbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2010&pages=1171-1177&author=A.+Ghofraniauthor=N.+W.+Morrellauthor=M.+M.+Hoeperauthor=H.+Olschewskiauthor=A.+J.+Peacockauthor=R.+J.+Barstauthor=S.+Shapiroauthor=H.+Golponauthor=M.+Toshnerauthor=F.+Grimmingerauthor=S.+Pascoe&title=Imatinib+in+pulmonary+arterial+hypertension+patients+with+inadequate+response+to+established+therapy&doi=10.1164%2Frccm.201001-0123OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy</span></div><div class="casAuthors">Ghofrani, Hossein A.; Morrell, Nicholas W.; Hoeper, Marius M.; Olschewski, Horst; Peacock, Andrew J.; Barst, Robyn J.; Shapiro, Shelley; Golpon, Heiko; Toshner, Mark; Grimminger, Friedrich; Pascoe, Steve</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1171-1177</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Pulmonary arterial hypertension (PAH) is a progressive condition with a poor prognosis.  Platelet-derived growth factor receptor (PDGFR) signaling plays an important role in its pathobiol.  Objectives: To assess safety, tolerability, and efficacy of the PDGFR inhibitor imatinib in patients with PAH.  Methods: Patients with PAH in functional classes II-IV were enrolled in a 24-wk randomized, double-blind, placebo-controlled pilot study.  Patients received imatinib (an inhibitor of PDGFR activity) 200 mg orally once daily (or placebo), which was increased to 400 mg if the initial dose was well tolerated.  The primary endpoints were safety and change from baseline in the 6-min-walk distance (6MWD).  Secondary endpoints included hemodynamics and functional classification.  Measurements and Main Results: Fifty-nine patients enrolled (imatinib [n = 28]; placebo [n = 31]); 42 completed the study.  Dropouts were equally matched between the two groups.  In the intention-to-treat (ITT) population there was no significant change in the 6MWD (mean ± SD) in the imatinib vs. placebo group (+22 ± 63 vs. -1.0 ± 53 m).  There was a significant decrease in pulmonary vascular resistance (imatinib -300 ± 347 vs. placebo -78 ± 269 dynes · s · cm-5, P < 0.01) and increase in cardiac output (imatinib +0.6 ± 1.2 vs. placebo -0.1 ± 0.9 L/min, P = 0.02).  Serious adverse events occurred in 11 imatinib recipients (39%) and 7 placebo recipients (23%).  Three deaths occurred in each group.  Post hoc subgroup analyses suggest that patients with greater hemodynamic impairment may respond better than patients with less impairment.  Conclusions: These data from a Phase II study are consistent with imatinib being well tolerated in patients with PAH, and provide proof of concept for further studies evaluating its safety, tolerability, and efficacy in PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO_t7qsxFoT7Vg90H21EOLACvtfcHk0li2tS2yEs8hzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFyhurbJ&md5=e9b087200bb9bed2266867e65841cee9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1164%2Frccm.201001-0123OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201001-0123OC%26sid%3Dliteratum%253Aachs%26aulast%3DGhofrani%26aufirst%3DA.%26aulast%3DMorrell%26aufirst%3DN.%2BW.%26aulast%3DHoeper%26aufirst%3DM.%2BM.%26aulast%3DOlschewski%26aufirst%3DH.%26aulast%3DPeacock%26aufirst%3DA.%2BJ.%26aulast%3DBarst%26aufirst%3DR.%2BJ.%26aulast%3DShapiro%26aufirst%3DS.%26aulast%3DGolpon%26aufirst%3DH.%26aulast%3DToshner%26aufirst%3DM.%26aulast%3DGrimminger%26aufirst%3DF.%26aulast%3DPascoe%26aufirst%3DS.%26atitle%3DImatinib%2520in%2520pulmonary%2520arterial%2520hypertension%2520patients%2520with%2520inadequate%2520response%2520to%2520established%2520therapy%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2010%26volume%3D182%26spage%3D1171%26epage%3D1177%26doi%3D10.1164%2Frccm.201001-0123OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Frost, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barst, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeper, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frantz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazzareno, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassoun, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrell, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonneau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapson, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DarioVizza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felser, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, D.</span><span> </span><span class="NLM_article-title">and Ghofrani, Long-term safety and efficacy of imatinib in pulmonary arterial hypertension</span> <span class="citation_source-journal">J. Heart. Lung. Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1366</span><span class="NLM_x">–</span> <span class="NLM_lpage">1375</span><span class="refDoi"> DOI: 10.1016/j.healun.2015.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1016%2Fj.healun.2015.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=26210752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FmsVyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1366-1375&author=A.+E.+Frostauthor=R.+J.+Barstauthor=M.+M.+Hoeperauthor=H.-J.+Changauthor=R.+P.+Frantzauthor=Y.+Fukumotoauthor=G.+N.+Nazzarenoauthor=P.+M.+Hassounauthor=H.+Kloseauthor=H.+Matsubaraauthor=N.+W.+Morrellauthor=A.+J.+Peacockauthor=M.+Pfeiferauthor=G.+Simonneauauthor=V.+F.+Tapsonauthor=F.+Torresauthor=C.+DarioVizzaauthor=D.+Lawrenceauthor=W.+Yangauthor=J.+M.+Felserauthor=D.+Quinn&title=and+Ghofrani%2C+Long-term+safety+and+efficacy+of+imatinib+in+pulmonary+arterial+hypertension&doi=10.1016%2Fj.healun.2015.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term safety and efficacy of imatinib in pulmonary arterial hypertension</span></div><div class="casAuthors">Frost Adaani E; Barst Robyn J; Hoeper Marius M; Chang Hyuk-Jae; Frantz Robert P; Fukumoto Yoshihiro; Galie Nazzareno; Hassoun Paul M; Klose Hans; Matsubara Hiromi; Morrell Nicholas W; Peacock Andrew J; Pfeifer Michael; Simonneau Gerald; Tapson Victor F; Torres Fernando; Dario Vizza Carmine; Lawrence David; Yang Wei; Felser James M; Quinn Deborah A; Ghofrani Hossein-Ardeschir</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1366-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Imatinib is an oral inhibitor of several protein kinases implicated in the pathophysiology of pulmonary hypertension.  Treatment with imatinib resulted in improved hemodynamics and exercise capacity in a controlled trial (Imatinib [QTI571] in Pulmonary Arterial Hypertension, a Randomized Efficacy Study [IMPRES]), among pulmonary arterial hypertension (PAH) patients inadequately responsive to 2 to 3 PAH-specific therapies.  METHODS:  The long-term (up to 204 weeks) safety and efficacy of imatinib in this open-label extension study were reviewed until early study termination on April 16, 2014.  Of 202 IMPRES-enrolled patients, 66 imatinib and 78 placebo recipients entered the extension.  RESULTS:  Overall, 93.8% (135 of 144) of patients discontinued the extension study; administrative issues (i.e., sponsor termination; 32.6%) and adverse events (31.3%) were the primary reasons for discontinuation.  Nine patients completed the extension study before it was terminated.  Serious and unexpected adverse events were frequent.  These included 6 subdural hematomas in the extension study and 17 deaths during or within 30 days of study end.  Although the patients who tolerated imatinib and remained in the extension for a longer duration did experience an improvement in functional class and walk distance, most discontinued the drug and the study.  CONCLUSIONS:  Severe adverse events, significant side effects, and a high discontinuation rate limit the utility of imatinib in the treatment of PAH.  These risks outweigh any possible improvements in hemodynamics and walk distance seen in those patients able to remain on drug.  The off-label use of this compound in PAH is discouraged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2vWkaw12dnszK395ZObgVfW6udTcc2ebsHuDRPW6rfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FmsVyjsA%253D%253D&md5=d4af0c5c1450214dfc06dfc3e1702e11</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.healun.2015.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.healun.2015.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DA.%2BE.%26aulast%3DBarst%26aufirst%3DR.%2BJ.%26aulast%3DHoeper%26aufirst%3DM.%2BM.%26aulast%3DChang%26aufirst%3DH.-J.%26aulast%3DFrantz%26aufirst%3DR.%2BP.%26aulast%3DFukumoto%26aufirst%3DY.%26aulast%3DNazzareno%26aufirst%3DG.%2BN.%26aulast%3DHassoun%26aufirst%3DP.%2BM.%26aulast%3DKlose%26aufirst%3DH.%26aulast%3DMatsubara%26aufirst%3DH.%26aulast%3DMorrell%26aufirst%3DN.%2BW.%26aulast%3DPeacock%26aufirst%3DA.%2BJ.%26aulast%3DPfeifer%26aufirst%3DM.%26aulast%3DSimonneau%26aufirst%3DG.%26aulast%3DTapson%26aufirst%3DV.%2BF.%26aulast%3DTorres%26aufirst%3DF.%26aulast%3DDarioVizza%26aufirst%3DC.%26aulast%3DLawrence%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DFelser%26aufirst%3DJ.%2BM.%26aulast%3DQuinn%26aufirst%3DD.%26atitle%3Dand%2520Ghofrani%252C%2520Long-term%2520safety%2520and%2520efficacy%2520of%2520imatinib%2520in%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DJ.%2520Heart.%2520Lung.%2520Transplant.%26date%3D2015%26volume%3D34%26spage%3D1366%26epage%3D1375%26doi%3D10.1016%2Fj.healun.2015.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7A"><span><span class="NLM_label">(A) </span><span class="NLM_contrib-group">Cooper, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span> </span><span class="NLM_article-title">Optimisation of DMPK by the inhaled route: challenges and approaches</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.2174/138920012800166571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7A&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.2174%2F138920012800166571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7A&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=22299825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7A&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=457-473&author=E.+A.+Cooperauthor=D.+Fergusonauthor=K.+Grime&title=Optimisation+of+DMPK+by+the+inhaled+route%3A+challenges+and+approaches&doi=10.2174%2F138920012800166571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7AR"><div class="casContent"><span class="casTitleNuber">7A</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of DMPK by the inhaled route: challenges and approaches</span></div><div class="casAuthors">Cooper, Anne E.; Ferguson, Douglas; Grime, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-473</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in inhalation delivery over recent years has led to an expansion in the understanding of lung pharmacokinetics.  Historically optimization of inhaled drugs focused largely on development of material properties, consistent with achieving a good lung deposition, alongside demonstrating appropriate in vivo efficacy with little understanding of the relationship to pharmacokinetics in the lung.  Recent efforts have led to an increased understanding of lung concns. and how to maximize exposure to achieve the desired pharmacol. response at a dose consistent with development of an inhaled product.  Although there is a prerequisite for excellent potency in inhalation delivery, it is essential that this be combined with pharmacokinetic properties that allow sufficient free concn. at the effect site in lung to exert the pharmacol. response for an appropriate dosing interval.  Increases in basicity, polarity and/or decreases in aq. soly. can extend pharmacokinetic duration and assist in finding the right balance between lung and systemic exposure.  Current evidence suggests there are similarities in lung retention in rat and dog and that animal lung concn. data can enable pharmacokinetic-pharmacodynamic relationships to be derived thus providing more confidence in the requirements for man.  Although inhaled delivery is challenging from a pharmacokinetic point of view, direct evaluation of exposure in the target organ has enabled further understanding of the drivers for drug disposition and highlighted the need for further development of predictive lung pharmacokinetic tools in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxztkVtHyCeLVg90H21EOLACvtfcHk0lgFp-nAjY1urw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D&md5=1dec4f52aeda55fe6ea888c289216d94</span></div><a href="/servlet/linkout?suffix=cit7A&amp;dbid=16384&amp;doi=10.2174%2F138920012800166571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920012800166571%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DE.%2BA.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGrime%26aufirst%3DK.%26atitle%3DOptimisation%2520of%2520DMPK%2520by%2520the%2520inhaled%2520route%253A%2520challenges%2520and%2520approaches%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2012%26volume%3D13%26spage%3D457%26epage%3D473%26doi%3D10.2174%2F138920012800166571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7B"><span><span class="NLM_label">(B) </span><span class="NLM_contrib-group">Tronde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lennernäs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, U.</span><span> </span><span class="NLM_article-title">Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1216</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span><span class="refDoi"> DOI: 10.1002/jps.10386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7B&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1002%2Fjps.10386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7B&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=12761811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7B&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1KisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=1216-1233&author=A.+Trondeauthor=B.+Nordenauthor=H.+Marchnerauthor=A.+Wendelauthor=H.+Lennern%C3%A4sauthor=U.+Bengtsson&title=Pulmonary+absorption+rate+and+bioavailability+of+drugs+in+vivo+in+rats%3A+structure-absorption+relationships+and+physicochemical+profiling+of+inhaled+drugs&doi=10.1002%2Fjps.10386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7BR"><div class="casContent"><span class="casTitleNuber">7B</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary absorption rate and bioavailability of drugs in vivo in rats: Structure-absorption relationships and physicochemical profiling of inhaled drugs</span></div><div class="casAuthors">Tronde, Ann; Norden, Bo; Marchner, Hans; Wendel, Anna-Karin; Lennernaes, Hans; Bengtsson, Ursula Hultkvist</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1216-1233</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The aim of this investigation was to analyze the structure-absorption relationships for pulmonary delivered drugs.  First, the inhaled drugs on the market during 2001 were identified and a profile of the calcd. physicochem. properties was made.  Second, an in vivo pharmacokinetic investigation was performed in anesthetized rats.  Eight selected drugs were administered by intratracheal nebulization and i.v. bolus administration and the plasma concns. of the drugs were detd. by LC-MS-MS.  Third, an evaluation of the relationships between the absorption/bioavailability data and the drugs' physicochem. characteristics and the epithelial permeability in Caco-2 cells, resp., was performed.  The drug absorption rate was found to correlate to the mol. polar surface area and the hydrogen bonding potential, as well as to the apparent permeability in Caco-2 cell monolayers, which indicated that passive diffusion was the predominating mechanism of absorption in the rat lung.  In contrast to the intestinal mucosa and the blood-brain barrier, the pulmonary epithelium was shown to be highly permeable to compds. with high mol. polar surface area (e.g., PSA 479 Å2).  Furthermore, a high bioavailability was found for the efflux transporter substrates talinolol (81%) and losartan (92%), which provides functional evidence for a quant. less important role for efflux transporters, such as P-glycoprotein, in limiting the absorption of these drugs from the rat lung.  In conclusion, the pulmonary route should be regarded as a potential alternative for the delivery of drugs that are inadequately absorbed after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-H1jPkrdCM7Vg90H21EOLACvtfcHk0lgFp-nAjY1urw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1KisLY%253D&md5=ab6a275a5ec7cf2cfad3aff031a87fab</span></div><a href="/servlet/linkout?suffix=cit7B&amp;dbid=16384&amp;doi=10.1002%2Fjps.10386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10386%26sid%3Dliteratum%253Aachs%26aulast%3DTronde%26aufirst%3DA.%26aulast%3DNorden%26aufirst%3DB.%26aulast%3DMarchner%26aufirst%3DH.%26aulast%3DWendel%26aufirst%3DA.%26aulast%3DLennern%25C3%25A4s%26aufirst%3DH.%26aulast%3DBengtsson%26aufirst%3DU.%26atitle%3DPulmonary%2520absorption%2520rate%2520and%2520bioavailability%2520of%2520drugs%2520in%2520vivo%2520in%2520rats%253A%2520structure-absorption%2520relationships%2520and%2520physicochemical%2520profiling%2520of%2520inhaled%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D1216%26epage%3D1233%26doi%3D10.1002%2Fjps.10386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Cazzola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calzetta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, M. G.</span><span> </span><span class="NLM_article-title">Pharmacology and therapeutics of bronchodilators</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1124/pr.111.004580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1124%2Fpr.111.004580" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=450-504&author=M.+Cazzolaauthor=C.+P.+Pageauthor=L.+Calzettaauthor=M.+G.+Matera&title=Pharmacology+and+therapeutics+of+bronchodilators&doi=10.1124%2Fpr.111.004580"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fpr.111.004580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.111.004580%26sid%3Dliteratum%253Aachs%26aulast%3DCazzola%26aufirst%3DM.%26aulast%3DPage%26aufirst%3DC.%2BP.%26aulast%3DCalzetta%26aufirst%3DL.%26aulast%3DMatera%26aufirst%3DM.%2BG.%26atitle%3DPharmacology%2520and%2520therapeutics%2520of%2520bronchodilators%26jtitle%3DPharmacol.%2520Rev.%26date%3D2012%26volume%3D64%26spage%3D450%26epage%3D504%26doi%3D10.1124%2Fpr.111.004580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheibe, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. P.</span><span> </span><span class="NLM_article-title">Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">31655</span><span class="NLM_x">–</span> <span class="NLM_lpage">31663</span><span class="refDoi"> DOI: 10.1074/jbc.M403319200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1074%2Fjbc.M403319200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=15123710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslOrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=31655-31663&author=C.+D.+Molauthor=D.+R.+Douganauthor=T.+R.+Schneiderauthor=R.+J.+Skeneauthor=M.+L.+Krausauthor=D.+N.+Scheibeauthor=G.+P.+Snellauthor=H.+Zouauthor=B.+C.+Sangauthor=K.+P.+Wilson&title=Structural+basis+for+the+autoinhibition+and+STI-571+inhibition+of+c-Kit+tyrosine+kinase&doi=10.1074%2Fjbc.M403319200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase</span></div><div class="casAuthors">Mol, Clifford D.; Dougan, Douglas R.; Schneider, Thomas R.; Skene, Robert J.; Kraus, Michelle L.; Scheibe, Daniel N.; Snell, Gyorgy P.; Zou, Hua; Sang, Bi-Ching; Wilson, Keith P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">31655-31663</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activity of the c-Kit receptor protein-tyrosine kinase is tightly regulated in normal cells, whereas deregulated c-Kit kinase activity is implicated in the pathogenesis of human cancers.  The c-Kit juxtamembrane region is known to have an autoinhibitory function; however the precise mechanism by which c-Kit is maintained in an autoinhibited state is not known.  We report the 1.9-Å resoln. crystal structure of native c-Kit kinase in an autoinhibited conformation and compare it with active c-Kit kinase.  Autoinhibited c-Kit is stabilized by the juxtamembrane domain, which inserts into the kinase-active site and disrupts formation of the activated structure.  A 1.6-Å crystal structure of c-Kit in complex with STI-571 (Imatinib or Gleevec) demonstrates that inhibitor binding disrupts this natural mechanism for maintaining c-Kit in an autoinhibited state.  Together, these results provide a structural basis for understanding c-Kit kinase autoinhibition and will facilitate the structure-guided design of specific inhibitors that target the activated and autoinhibited conformations of c-Kit kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWJsKx1IzXQbVg90H21EOLACvtfcHk0lgkwdIDR5Okjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslOrtrc%253D&md5=df6065a62b44e4c2e6b020da0f797ab4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M403319200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M403319200%26sid%3Dliteratum%253Aachs%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DScheibe%26aufirst%3DD.%2BN.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DWilson%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520autoinhibition%2520and%2520STI-571%2520inhibition%2520of%2520c-Kit%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D31655%26epage%3D31663%26doi%3D10.1074%2Fjbc.M403319200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bruce, I.; Chamoin, S.; Collingwood, S. P.; Furet, P.; Furminger, V.; Lewis, S.; Loren, J. C.; Molteni, V.; Saunders, A. M.; Shaw, D.; Sviridenko, L.; Thomson, C.; Yeh, V.; Janus, D.; West, R.</span><span> </span><span class="NLM_article-title">Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension</span>. Patent WO2013030802, March 7, 2013.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bruce%2C+I.%3B+Chamoin%2C+S.%3B+Collingwood%2C+S.+P.%3B+Furet%2C+P.%3B+Furminger%2C+V.%3B+Lewis%2C+S.%3B+Loren%2C+J.+C.%3B+Molteni%2C+V.%3B+Saunders%2C+A.+M.%3B+Shaw%2C+D.%3B+Sviridenko%2C+L.%3B+Thomson%2C+C.%3B+Yeh%2C+V.%3B+Janus%2C+D.%3B+West%2C+R.+Bicyclic+heterocycle+derivatives+for+the+treatment+of+pulmonary+arterial+hypertension.+Patent+WO2013030802%2C+March+7%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBruce%26aufirst%3DI.%26atitle%3DBicyclic%2520heterocycle%2520derivatives%2520for%2520the%2520treatment%2520of%2520pulmonary%2520arterial%2520hypertension" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="note"><p class="first last">Average of <i>N</i> = 3 test occasions. The effect of the test compound on the phosphorylation of a probe peptide substrate by PDGFRα was measured via capillary electrophoresis on a Caliper Labchip 3000 machine. The measurements could be used to determine an IC<sub>50</sub> in a high throughput manner</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">Average of <i>N</i> = 3 test occasions. For full procedure refer to the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf" class="ext-link">Supporting Information</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">%Transcellular readings from the PAMPA assay were used as an increased resolution was seen at very low permeability rates by using this parameter.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">DeSimone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darrow, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span> </span><span class="NLM_article-title">Privileged structures: applications in drug discovery</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.2174/1386207043328544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.2174%2F1386207043328544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=15320713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFegsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=473-494&author=R.+W.+DeSimoneauthor=K.+S.+Currieauthor=S.+A.+Mitchellauthor=J.+W.+Darrowauthor=D.+A.+Pippin&title=Privileged+structures%3A+applications+in+drug+discovery&doi=10.2174%2F1386207043328544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged structures: Applications in drug discovery</span></div><div class="casAuthors">DeSimone, R. W.; Currie, K. S.; Mitchell, S. A.; Darrow, J. W.; Pippin, D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">473-493</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past 15 yr the privileged structure concept has emerged as a fruitful approach to the discovery of novel biol. active mols.  Privileged structures are mol. scaffolds with versatile binding properties, such that a single scaffold is able to provide potent and selective ligands for a range of different biol. targets through modification of functional groups.  In addn., privileged structures typically exhibit good drug-like properties, which in turn leads to more drug-like compd. libraries and leads.  The net result is the prodn. of high quality leads that provide a solid foundation for further development.  The identification of privileged structures will be discussed, emphasizing the importance of understanding the structure-target relationships that confer "privileged" status.  This understanding allows privileged structure based libraries to be targeted at distinct target families (e.g. GPCRs, LGIC, enzymes/kinases).  Privileged structures have been successfully exploited across and within different target families and promises to be an effective approach to the discovery and optimization of novel bioactive mols.  The application of the privileged structure approach, both in traditional medicinal chem. and in the design of focused libraries, will be discussed with the aid of illustrative examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIDSZoRtfibVg90H21EOLACvtfcHk0lgkwdIDR5Okjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFegsrY%253D&md5=165b976f9d6c6d38d752cabf2c647a48</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1386207043328544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207043328544%26sid%3Dliteratum%253Aachs%26aulast%3DDeSimone%26aufirst%3DR.%2BW.%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26aulast%3DDarrow%26aufirst%3DJ.%2BW.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26atitle%3DPrivileged%2520structures%253A%2520applications%2520in%2520drug%2520discovery%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2004%26volume%3D7%26spage%3D473%26epage%3D494%26doi%3D10.2174%2F1386207043328544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Valko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, M. H.</span><span> </span><span class="NLM_article-title">Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1002/1520-6017(200008)89:8<1085::AID-JPS13>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1002%2F1520-6017%28200008%2989%3A8%3C1085%3A%3AAID-JPS13%3E3.0.CO%3B2-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2000&pages=1085-1096&author=K.+Valkoauthor=C.+M.+Duauthor=C.+D.+Bevanauthor=D.+P.+Reynoldsauthor=M.+H.+Abraham&title=Rapid-gradient+HPLC+method+for+measuring+drug+interactions+with+immobilized+artificial+membrane%3A+comparison+with+other+lipophilicity+measures&doi=10.1002%2F1520-6017%28200008%2989%3A8%3C1085%3A%3AAID-JPS13%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2F1520-6017%28200008%2989%3A8%3C1085%3A%3AAID-JPS13%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1520-6017%2528200008%252989%253A8%253C1085%253A%253AAID-JPS13%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DDu%26aufirst%3DC.%2BM.%26aulast%3DBevan%26aufirst%3DC.%2BD.%26aulast%3DReynolds%26aufirst%3DD.%2BP.%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26atitle%3DRapid-gradient%2520HPLC%2520method%2520for%2520measuring%2520drug%2520interactions%2520with%2520immobilized%2520artificial%2520membrane%253A%2520comparison%2520with%2520other%2520lipophilicity%2520measures%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D89%26spage%3D1085%26epage%3D1096%26doi%3D10.1002%2F1520-6017%28200008%2989%3A8%3C1085%3A%3AAID-JPS13%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mallik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briscoe, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hage, D. S.</span><span> </span><span class="NLM_article-title">Analysis of drug-protein binding by ultra fast affinity chromatography using immobilized human serum albumin</span> <span class="citation_source-journal">J. Chromatogr. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1217</span><span class="NLM_x">, </span> <span class="NLM_fpage">2796</span><span class="NLM_x">–</span> <span class="NLM_lpage">2803</span><span class="refDoi"> DOI: 10.1016/j.chroma.2010.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1016%2Fj.chroma.2010.02.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1217&publication_year=2010&pages=2796-2803&author=R.+Mallikauthor=M.+J.+Yooauthor=C.+J.+Briscoeauthor=D.+S.+Hage&title=Analysis+of+drug-protein+binding+by+ultra+fast+affinity+chromatography+using+immobilized+human+serum+albumin&doi=10.1016%2Fj.chroma.2010.02.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2010.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2010.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DMallik%26aufirst%3DR.%26aulast%3DYoo%26aufirst%3DM.%2BJ.%26aulast%3DBriscoe%26aufirst%3DC.%2BJ.%26aulast%3DHage%26aufirst%3DD.%2BS.%26atitle%3DAnalysis%2520of%2520drug-protein%2520binding%2520by%2520ultra%2520fast%2520affinity%2520chromatography%2520using%2520immobilized%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D2010%26volume%3D1217%26spage%3D2796%26epage%3D2803%26doi%3D10.1016%2Fj.chroma.2010.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etheridge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. A.</span><span> </span><span class="NLM_article-title">Studies in drug albumin binding using HSA and RSA affinity methods</span> <span class="citation_source-journal">J. Liq. Chromatogr. Relat. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1080/10826076.2011.548299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1080%2F10826076.2011.548299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVShtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=317-327&author=J.+Reillyauthor=D.+Etheridgeauthor=B.+Everattauthor=Z.+Jiangauthor=C.+Springerauthor=R.+A.+Fairhurst&title=Studies+in+drug+albumin+binding+using+HSA+and+RSA+affinity+methods&doi=10.1080%2F10826076.2011.548299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Studies in drug albumin binding using HSA and RSA affinity methods</span></div><div class="casAuthors">Reilly, John; Etheridge, Donnya; Everatt, Brian; Jiang, Zheng-jin; Aldcroft, Clive; Wright, Penny; Clemens, Ian; Cox, Brian; Press, Neil J.; Watson, Simon; Porter, David; Springer, Clayton; Fairhurst, Robin A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liquid Chromatography & Related Technologies</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-327</span>CODEN:
                <span class="NLM_cas:coden">JLCTFC</span>;
        ISSN:<span class="NLM_cas:issn">1082-6076</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A HPLC gradient methodol. using immobilized human serum albumin (HSA) and rat serum albumin (RSA) has been used as a tool to investigate the protein binding trends of novel discovery compds.  These methods have been set up to support a high throughput approach and have been shown to be complementary to one another.  Significant binding differences have been obsd. with some compds. when both methods have been employed.  Discovery chemists are now also able to rank order mols. using these quick "trend anal." albumin binding screens by submitting a 20 μl sample from the 10 mM stock soln. from the inhouse compd. archive.  Addnl., chemists have the opportunity to predict trends in albumin binding by use of an internal QSAR model based upon a diverse 1200 compd. result set, which had been previously analyzed with the HSA methodol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3I_bdVVhi6rVg90H21EOLACvtfcHk0lgbm9evjhAhZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVShtbo%253D&md5=519ddd9fc72d2e8c6f16fbc79c4c3fcb</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1080%2F10826076.2011.548299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10826076.2011.548299%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DEtheridge%26aufirst%3DD.%26aulast%3DEveratt%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DFairhurst%26aufirst%3DR.%2BA.%26atitle%3DStudies%2520in%2520drug%2520albumin%2520binding%2520using%2520HSA%2520and%2520RSA%2520affinity%2520methods%26jtitle%3DJ.%2520Liq.%2520Chromatogr.%2520Relat.%2520Technol.%26date%3D2011%26volume%3D34%26spage%3D317%26epage%3D327%26doi%3D10.1080%2F10826076.2011.548299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">Details of occupancy assay are in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf" class="ext-link">Supporting Information</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">Database of in vitro and in silico properties of the compounds tesed in vivo is part of the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span>Supplied by Cell Signaling Technology (<a href="http://www.cellsignal.com" class="extLink">www.cellsignal.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Supplied+by+Cell+Signaling+Technology+%28www.cellsignal.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hollósy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkó, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunhuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kéri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, C.</span><span> </span><span class="NLM_article-title">Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6958</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1021/jm050957i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050957i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ClurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6958-71&author=F.+Holl%C3%B3syauthor=K.+Valk%C3%B3author=A.+Herseyauthor=S.+Nunhuckauthor=G.+K%C3%A9riauthor=C.+Bevan&title=Estimation+of+volume+of+distribution+in+humans+from+high+throughput+HPLC-based+measurements+of+human+serum+albumin+binding+and+immobilized+artificial+membrane+partitioning&doi=10.1021%2Fjm050957i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of Volume of Distribution in Humans from High Throughput HPLC-Based Measurements of Human Serum Albumin Binding and Immobilized Artificial Membrane Partitioning</span></div><div class="casAuthors">Hollosy, Ferenc; Valko, Klara; Hersey, Anne; Nunhuck, Shenaz; Keri, Gyoergy; Bevan, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6958-6971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The vol. of distribution (VD) in humans of 179 known drug mols. (acids, bases, and neutrals) has been modeled using two biomimetic-binding measurements.  The phospholipid binding (log K (IAM)) and the plasma protein binding (log K (HSA)) have been calcd. from gradient HPLC retention times on immobilized artificial membrane (IAM) and on human serum albumin (HSA) columns, resp.  The log VD values showed good correlation with the compds.' relative binding to IAM and HSA as follows: log VD = 0.44 log K (IAM) - 0.22 log K (HSA) - 0.66; n = 179, r2 = 0.76, s = 0.33, and F = 272.  It was also obsd. that pos. charged mols. bind relatively more to IAM, while neg. charged ones bind more to HSA, in line with the empirical observation that bases tend to have a larger vol. of distribution than acids.  These results suggest that with the help of these two simple high throughput HPLC-based biomimetic binding measurements an important in vivo drug disposition property can be estd. for use in early drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBHWlrSQHQUbVg90H21EOLACvtfcHk0lgbm9evjhAhZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ClurfK&md5=e19a0a058e052287cdca97c2125f9da4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm050957i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050957i%26sid%3Dliteratum%253Aachs%26aulast%3DHoll%25C3%25B3sy%26aufirst%3DF.%26aulast%3DValk%25C3%25B3%26aufirst%3DK.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DBevan%26aufirst%3DC.%26atitle%3DEstimation%2520of%2520volume%2520of%2520distribution%2520in%2520humans%2520from%2520high%2520throughput%2520HPLC-based%2520measurements%2520of%2520human%2520serum%2520albumin%2520binding%2520and%2520immobilized%2520artificial%2520membrane%2520partitioning%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6958%26epage%3D71%26doi%3D10.1021%2Fjm050957i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loscalzo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Y.</span><span> </span><span class="NLM_article-title">Serial noninvasive assessment of progressive pulmonary hypertension in a rat model</span> <span class="citation_source-journal">Am. J. Physiol. Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">H364</span><span class="NLM_x">–</span> <span class="NLM_lpage">H371</span><span class="refDoi"> DOI: 10.1152/ajpheart.00979.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1152%2Fajpheart.00979.2001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2002&pages=H364-H371&author=J.+E.+Jonesauthor=L.+Mendesauthor=M.+A.+Ruddauthor=G.+Russoauthor=J.+Loscalzoauthor=Y.-Y.+Zhang&title=Serial+noninvasive+assessment+of+progressive+pulmonary+hypertension+in+a+rat+model&doi=10.1152%2Fajpheart.00979.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00979.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00979.2001%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BE.%26aulast%3DMendes%26aufirst%3DL.%26aulast%3DRudd%26aufirst%3DM.%2BA.%26aulast%3DRusso%26aufirst%3DG.%26aulast%3DLoscalzo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.-Y.%26atitle%3DSerial%2520noninvasive%2520assessment%2520of%2520progressive%2520pulmonary%2520hypertension%2520in%2520a%2520rat%2520model%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2002%26volume%3D283%26spage%3DH364%26epage%3DH371%26doi%3D10.1152%2Fajpheart.00979.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gomez-Arroyo, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farkas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhussaini, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farkas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraskauskas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voelkel, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogaard, H. J.</span><span> </span><span class="NLM_article-title">The monocrotaline model of pulmonary hypertension in perspective</span> <span class="citation_source-journal">Am. J. Physiol. Lung Cell Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">L363</span><span class="NLM_x">–</span> <span class="NLM_lpage">L369</span><span class="refDoi"> DOI: 10.1152/ajplung.00212.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1152%2Fajplung.00212.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=21964406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFKns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2012&pages=L363-L369&author=J.+G.+Gomez-Arroyoauthor=L.+Farkasauthor=A.+A.+Alhussainiauthor=D.+Farkasauthor=D.+Kraskauskasauthor=N.+F.+Voelkelauthor=H.+J.+Bogaard&title=The+monocrotaline+model+of+pulmonary+hypertension+in+perspective&doi=10.1152%2Fajplung.00212.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">The monocrotaline model of pulmonary hypertension in perspective</span></div><div class="casAuthors">Gomez-Arroyo, Jose G.; Farkas, Laszlo; Alhussaini, Aysar A.; Farkas, Daniela; Kraskauskas, Donatas; Voelkel, Norbert F.; Bogaard, Harm J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">L363-L369</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Severe forms of pulmonary arterial hypertension (PAH) are characterized by various degrees of remodeling of the pulmonary arterial vessels, which increases the pulmonary vascular resistance and right ventricular afterload, thus contributing to the development of right ventricle dysfunction and failure.  Recent years have seen advances in the understanding of the pathobiol. of PAH; however, many important questions remain unanswered.  Elucidating the pathobiol. of PAH continues to be crit. to design new effective therapeutic strategies, and appropriate animal models of PAH are necessary to achieve the task.  Although the monocrotaline rat model of PAH has contributed to a better understanding of vascular remodeling in pulmonary hypertension, we question the validity of this model as a preclinically relevant model of severe plexogenic PAH.  Here we review pertinent publications that either have been forgotten or ignored, and we reexamine the monocrotaline model in the context of human forms of PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfhQAJlfdHW7Vg90H21EOLACvtfcHk0lgWVLV8rwoIVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFKns78%253D&md5=bc1f51b0ed2a5a71e02974c1e51a0474</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00212.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00212.2011%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Arroyo%26aufirst%3DJ.%2BG.%26aulast%3DFarkas%26aufirst%3DL.%26aulast%3DAlhussaini%26aufirst%3DA.%2BA.%26aulast%3DFarkas%26aufirst%3DD.%26aulast%3DKraskauskas%26aufirst%3DD.%26aulast%3DVoelkel%26aufirst%3DN.%2BF.%26aulast%3DBogaard%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520monocrotaline%2520model%2520of%2520pulmonary%2520hypertension%2520in%2520perspective%26jtitle%3DAm.%2520J.%2520Physiol.%2520Lung%2520Cell%2520Mol.%2520Physiol.%26date%3D2012%26volume%3D302%26spage%3DL363%26epage%3DL369%26doi%3D10.1152%2Fajplung.00212.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Stenmark, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurtry, I. F.</span><span> </span><span class="NLM_article-title">Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure</span> <span class="citation_source-journal">Am. J. Physiol. Lung Cell Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">L1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">L1032</span><span class="refDoi"> DOI: 10.1152/ajplung.00217.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1152%2Fajplung.00217.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=19748998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOgtr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=L1013-L1032&author=K.+R.+Stenmarkauthor=B.+Meyrickauthor=N.+Galieauthor=W.+J.+Mooiauthor=I.+F.+McMurtry&title=Animal+models+of+pulmonary+arterial+hypertension%3A+the+hope+for+etiological+discovery+and+pharmacological+cure&doi=10.1152%2Fajplung.00217.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure</span></div><div class="casAuthors">Stenmark, Kurt R.; Meyrick, Barbara; Galie, Nazzareno; Mooi, Wolter J.; McMurtry, Ivan F.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">6, Pt. 1</span>),
    <span class="NLM_cas:pages">L1013-L1032</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  At present, six groups of chronic pulmonary hypertension (PH) are described.  Among these, group 1 (and 1') comprises a group of diverse diseases termed pulmonary arterial hypertension (PAH) that have several pathophysiol., histol., and prognostic features in common.  PAH is a particularly severe and progressive form of PH that frequently leads to right heart failure and premature death.  The diagnosis of PAH must include a series of defined clin. parameters, which extend beyond mere elevations in pulmonary arterial pressures and include precapillary PH, pulmonary hypertensive arteriopathy (usually with plexiform lesions), slow clin. onset (months or years), and a chronic time course (years) characterized by progressive deterioration.  What appears to distinguish PAH from other forms of PH is the severity of the arteriopathy obsd., the defining characteristic of which is "plexogenic arteriopathy.".  The pathogenesis of this arteriopathy remains unclear despite intense investigation in a variety of animal model systems.  The most commonly used animal models ("classic" models) are rodents exposed to either hypoxia or monocrotaline.  Newer models, which involve modification of classic approaches, have been developed that exhibit more severe PH and vascular lesions, which include neointimal proliferation and occlusion of small vessels.  In addn., genetically manipulated mice have been generated that have provided insight into the role of specific mols. in the pulmonary hypertensive process.  Unfortunately, at present, there is no perfect preclin. model that completely recapitulates human PAH.  All models, however, have provided and will continue to provide invaluable insight into the numerous pathways that contribute to the development and maintenance of PH.  Use of both classic and newly developed animal models will allow continued rigorous testing of new hypotheses regarding pathogenesis and treatment.  This review highlights progress that has been made in animal modeling of this important human condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQp6B2ETV6lbVg90H21EOLACvtfcHk0lgWVLV8rwoIVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOgtr%252FO&md5=8ba257a084e50c70e2d73cb3bdff0655</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00217.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00217.2009%26sid%3Dliteratum%253Aachs%26aulast%3DStenmark%26aufirst%3DK.%2BR.%26aulast%3DMeyrick%26aufirst%3DB.%26aulast%3DGalie%26aufirst%3DN.%26aulast%3DMooi%26aufirst%3DW.%2BJ.%26aulast%3DMcMurtry%26aufirst%3DI.%2BF.%26atitle%3DAnimal%2520models%2520of%2520pulmonary%2520arterial%2520hypertension%253A%2520the%2520hope%2520for%2520etiological%2520discovery%2520and%2520pharmacological%2520cure%26jtitle%3DAm.%2520J.%2520Physiol.%2520Lung%2520Cell%2520Mol.%2520Physiol.%26date%3D2009%26volume%3D297%26spage%3DL1013%26epage%3DL1032%26doi%3D10.1152%2Fajplung.00217.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Bruce, I.; Chamoin, S.; Furet, P.; Furminger, V.; Lewis, S.; Loren, J.; Lin, L. V.; Molteni, V.; Saunders, A. M.; Shaw, D. E.; Turner, R.; Yeh, V.</span><span class="NLM_x"> (</span><span class="NLM_year">2014</span><span class="NLM_x">) </span><span> </span><span class="NLM_article-title">Solid forms of bicyclic heterocyclic derivatives as pdgf receptor mediators</span>. Patent WO2014132220, September 4, 2014.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=I.+Bruce&author=S.+Chamoin&author=P.+Furet&author=V.+Furminger&author=S.+Lewis&author=J.+Loren&author=L.+V.+Lin&author=V.+Molteni&author=A.+M.+Saunders&author=D.+E.+Shaw&author=R.+Turner&author=V.+Yeh&title=Solid+forms+of+bicyclic+heterocyclic+derivatives+as+pdgf+receptor+mediators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBruce%26aufirst%3DI.%26date%3D2014%26atitle%3DSolid%2520forms%2520of%2520bicyclic%2520heterocyclic%2520derivatives%2520as%2520pdgf%2520receptor%2520mediators" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0ljG5gBNIzwJEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7A','cit7B'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':[],'ref12':[],'ref13':[],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':[],'ref18':[],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chada Raji Reddy, Santosh Kumar Prajapti, <span class="NLM_string-name hlFld-ContribAuthor">Ravi Ranjan</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(I)-Catalyzed Aminative Aza-Annulation of Enynyl Azide using N-Fluorobenzenesulfonimide: Synthesis of 5-Aminonicotinates. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (10)
                                     , 3128-3131. <a href="https://doi.org/10.1021/acs.orglett.8b01228" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01228%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCu%252528I%252529-Catalyzed%252BAminative%252BAza-Annulation%252Bof%252BEnynyl%252BAzide%252Busing%252BN-Fluorobenzenesulfonimide%25253A%252BSynthesis%252Bof%252B5-Aminonicotinates%26aulast%3DReddy%26aufirst%3DChada%2BRaji%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18042018%26date%3D30042018%26volume%3D20%26issue%3D10%26spage%3D3128%26epage%3D3131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amelia  Freeman</span>, <span class="hlFld-ContribAuthor ">Luhua  Qiao</span>, <span class="hlFld-ContribAuthor ">Nelida  Olave</span>, <span class="hlFld-ContribAuthor ">Gabriel  Rezonzew</span>, <span class="hlFld-ContribAuthor ">Samuel  Gentle</span>, <span class="hlFld-ContribAuthor ">Brian  Halloran</span>, <span class="hlFld-ContribAuthor ">Gloria S.  Pryhuber</span>, <span class="hlFld-ContribAuthor ">Amit  Gaggar</span>, <span class="hlFld-ContribAuthor ">Trent E.  Tipple</span>, <span class="hlFld-ContribAuthor ">Namasivayam  Ambalavanan</span>, <span class="hlFld-ContribAuthor ">Charitharth Vivek  Lal</span>. </span><span class="cited-content_cbyCitation_article-title">MicroRNA 219-5p inhibits alveolarization by reducing platelet derived growth factor receptor-alpha. </span><span class="cited-content_cbyCitation_journal-name">Respiratory Research</span><span> <strong>2021,</strong> <em>22 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12931-021-01654-7" title="DOI URL">https://doi.org/10.1186/s12931-021-01654-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12931-021-01654-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12931-021-01654-7%26sid%3Dliteratum%253Aachs%26jtitle%3DRespiratory%2520Research%26atitle%3DMicroRNA%252B219-5p%252Binhibits%252Balveolarization%252Bby%252Breducing%252Bplatelet%252Bderived%252Bgrowth%252Bfactor%252Breceptor-alpha%26aulast%3DFreeman%26aufirst%3DAmelia%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Britta  Bonn</span>, <span class="hlFld-ContribAuthor ">Matthew  Perry</span>. </span><span class="cited-content_cbyCitation_article-title">The API. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 13-34. <a href="https://doi.org/10.1016/B978-0-12-814974-4.00006-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-814974-4.00006-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-814974-4.00006-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-814974-4.00006-7%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BAPI%26aulast%3DBonn%26aufirst%3DBritta%26date%3D2021%26spage%3D13%26epage%3D34%26pub%3DElsevier%26atitle%3DInhaled%252BMedicines%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maneesh Kumar Reddy  Singam</span>, <span class="hlFld-ContribAuthor ">Attunuri  Nagireddy</span>, <span class="hlFld-ContribAuthor ">Manda  Rajesh</span>, <span class="hlFld-ContribAuthor ">Veeramalla  Ganesh</span>, <span class="hlFld-ContribAuthor ">Maddi Sridhar  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Ni-Catalyzed electrophile driven regioselective arylative cyclization of
              ortho
              -functional diaryl acetylenes for the synthesis of pyridine and indene derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (1)
                                     , 30-34. <a href="https://doi.org/10.1039/C9QO01266D" title="DOI URL">https://doi.org/10.1039/C9QO01266D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9QO01266D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9QO01266D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DNi-Catalyzed%252Belectrophile%252Bdriven%252Bregioselective%252Barylative%252Bcyclization%252Bof%252Bortho%252B-functional%252Bdiaryl%252Bacetylenes%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpyridine%252Band%252Bindene%252Bderivatives%26aulast%3DSingam%26aufirst%3DManeesh%2BKumar%2BReddy%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D1%26spage%3D30%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Hart S.  Dengler</span>, <span class="hlFld-ContribAuthor ">Naomi S.  Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126658. <a href="https://doi.org/10.1016/j.bmcl.2019.126658" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126658%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhaled%252BJanus%252BKinase%252B%252528JAK%252529%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Basthma%26aulast%3DZak%26aufirst%3DMark%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donglu  Zhang</span>, <span class="hlFld-ContribAuthor ">Cornelis E.C.A.  Hop</span>, <span class="hlFld-ContribAuthor ">Gabriela  Patilea-Vrana</span>, <span class="hlFld-ContribAuthor ">Gautham  Gampa</span>, <span class="hlFld-ContribAuthor ">Herana Kamal  Seneviratne</span>, <span class="hlFld-ContribAuthor ">Jashvant D.  Unadkat</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Karthik  Nagapudi</span>, <span class="hlFld-ContribAuthor ">Li  Di</span>, <span class="hlFld-ContribAuthor ">Lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Wright</span>, <span class="hlFld-ContribAuthor ">Namandjé N.  Bumpus</span>, <span class="hlFld-ContribAuthor ">Richard  Zang</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Yurong  Lai</span>, <span class="hlFld-ContribAuthor ">S. Cyrus  Khojasteh</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule–Related Therapeutic Modalities. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2019,</strong> <em>47 </em>
                                    (10)
                                     , 1122-1135. <a href="https://doi.org/10.1124/dmd.119.086744" title="DOI URL">https://doi.org/10.1124/dmd.119.086744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.119.086744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.119.086744%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DDrug%252BConcentration%252BAsymmetry%252Bin%252BTissues%252Band%252BPlasma%252Bfor%252BSmall%252BMolecule%2525E2%252580%252593Related%252BTherapeutic%252BModalities%26aulast%3DZhang%26aufirst%3DDonglu%26date%3D2019%26date%3D2019%26volume%3D47%26issue%3D10%26spage%3D1122%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pieter  Vrijens</span>, <span class="hlFld-ContribAuthor ">Sam  Noppen</span>, <span class="hlFld-ContribAuthor ">Talitha  Boogaerts</span>, <span class="hlFld-ContribAuthor ">Els  Vanstreels</span>, <span class="hlFld-ContribAuthor ">Roberto  Ronca</span>, <span class="hlFld-ContribAuthor ">Paola  Chiodelli</span>, <span class="hlFld-ContribAuthor ">Manon  Laporte</span>, <span class="hlFld-ContribAuthor ">Evelien  Vanderlinden</span>, <span class="hlFld-ContribAuthor ">Sandra  Liekens</span>, <span class="hlFld-ContribAuthor ">Annelies  Stevaert</span>, <span class="hlFld-ContribAuthor ">Lieve  Naesens</span>. </span><span class="cited-content_cbyCitation_article-title">Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of General Virology</span><span> <strong>2019,</strong> <em>100 </em>
                                    (4)
                                     , 583-601. <a href="https://doi.org/10.1099/jgv.0.001235" title="DOI URL">https://doi.org/10.1099/jgv.0.001235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1099/jgv.0.001235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1099%2Fjgv.0.001235%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520General%2520Virology%26atitle%3DInfluenza%252Bvirus%252Bentry%252Bvia%252Bthe%252BGM3%252Bganglioside-mediated%252Bplatelet-derived%252Bgrowth%252Bfactor%252Breceptor%252B%2525CE%2525B2%252Bsignalling%252Bpathway%26aulast%3DVrijens%26aufirst%3DPieter%26date%3D2019%26volume%3D100%26issue%3D4%26spage%3D583%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elin  Boger</span>, <span class="hlFld-ContribAuthor ">Markus  Fridén</span>. </span><span class="cited-content_cbyCitation_article-title">Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Aerosol Medicine and Pulmonary Drug Delivery</span><span> <strong>2019,</strong> <em>32 </em>
                                    (1)
                                     , 1-12. <a href="https://doi.org/10.1089/jamp.2017.1436" title="DOI URL">https://doi.org/10.1089/jamp.2017.1436</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/jamp.2017.1436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fjamp.2017.1436%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Aerosol%2520Medicine%2520and%2520Pulmonary%2520Drug%2520Delivery%26atitle%3DPhysiologically%252BBased%252BPharmacokinetic%25252FPharmacodynamic%252BModeling%252BAccurately%252BPredicts%252Bthe%252BBetter%252BBronchodilatory%252BEffect%252Bof%252BInhaled%252BVersus%252BOral%252BSalbutamol%252BDosage%252BForms%26aulast%3DBoger%26aufirst%3DElin%26date%3D2019%26volume%3D32%26issue%3D1%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elin  Boger</span>, <span class="hlFld-ContribAuthor ">Oskar  Wigström</span>. </span><span class="cited-content_cbyCitation_article-title">A Partial Differential Equation Approach to Inhalation Physiologically Based Pharmacokinetic Modeling. </span><span class="cited-content_cbyCitation_journal-name">CPT: Pharmacometrics & Systems Pharmacology</span><span> <strong>2018,</strong> <em>7 </em>
                                    (10)
                                     , 638-646. <a href="https://doi.org/10.1002/psp4.12344" title="DOI URL">https://doi.org/10.1002/psp4.12344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/psp4.12344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpsp4.12344%26sid%3Dliteratum%253Aachs%26jtitle%3DCPT%253A%2520Pharmacometrics%2520%2526%2520Systems%2520Pharmacology%26atitle%3DA%252BPartial%252BDifferential%252BEquation%252BApproach%252Bto%252BInhalation%252BPhysiologically%252BBased%252BPharmacokinetic%252BModeling%26aulast%3DBoger%26aufirst%3DElin%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D10%26spage%3D638%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramon  Hendrickx</span>, <span class="hlFld-ContribAuthor ">Eva  Lamm Bergström</span>, <span class="hlFld-ContribAuthor ">David L. I.  Janzén</span>, <span class="hlFld-ContribAuthor ">Markus  Fridén</span>, <span class="hlFld-ContribAuthor ">Ulf  Eriksson</span>, <span class="hlFld-ContribAuthor ">Ken  Grime</span>, <span class="hlFld-ContribAuthor ">Douglas  Ferguson</span>. </span><span class="cited-content_cbyCitation_article-title">Translational Model to Predict Pulmonary Pharmacokinetics and Efficacy in Man for Inhaled Bronchodilators. </span><span class="cited-content_cbyCitation_journal-name">CPT: Pharmacometrics & Systems Pharmacology</span><span> <strong>2018,</strong> <em>7 </em>
                                    (3)
                                     , 147-157. <a href="https://doi.org/10.1002/psp4.12270" title="DOI URL">https://doi.org/10.1002/psp4.12270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/psp4.12270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpsp4.12270%26sid%3Dliteratum%253Aachs%26jtitle%3DCPT%253A%2520Pharmacometrics%2520%2526%2520Systems%2520Pharmacology%26atitle%3DTranslational%252BModel%252Bto%252BPredict%252BPulmonary%252BPharmacokinetics%252Band%252BEfficacy%252Bin%252BMan%252Bfor%252BInhaled%252BBronchodilators%26aulast%3DHendrickx%26aufirst%3DRamon%26date%3D2018%26date%3D2017%26volume%3D7%26issue%3D3%26spage%3D147%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugen  Bethke</span>, <span class="hlFld-ContribAuthor ">Boris  Pinchuk</span>, <span class="hlFld-ContribAuthor ">Christian  Renn</span>, <span class="hlFld-ContribAuthor ">Lydia  Witt</span>, <span class="hlFld-ContribAuthor ">Joachim  Schlosser</span>, <span class="hlFld-ContribAuthor ">Christian  Peifer</span>. </span><span class="cited-content_cbyCitation_article-title">From Type I to Type II: Design, Synthesis, and Characterization of Potent Pyrazin-2-ones as DFG-Out Inhibitors of PDGFRβ. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (24)
                                     , 2664-2674. <a href="https://doi.org/10.1002/cmdc.201600494" title="DOI URL">https://doi.org/10.1002/cmdc.201600494</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600494%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DFrom%252BType%2525E2%252580%252585I%252Bto%252BType%2525E2%252580%252585II%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BCharacterization%252Bof%252BPotent%252BPyrazin-2-ones%252Bas%252BDFG-Out%252BInhibitors%252Bof%252BPDGFR%2525CE%2525B2%26aulast%3DBethke%26aufirst%3DEugen%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D24%26spage%3D2664%26epage%3D2674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead molecules identified from the Novartis sample collection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. General scheme for preparation of the compounds described. For specific structures of R<sup>1</sup> and R<sup>2</sup> refer to Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and 2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Preparation of the pyridine core.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Synthesis of (5,5-dimethyltetrahydrofuran-2-yl) methanamine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking of <b>7c</b> into the homology model generated from the PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46">1T46</a> (<b>1</b> cocrystallized with cKit).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (A) The position of <b>1</b> (cyan) compared to the proposed binding mode for <b>7c</b> (orange). (B) The potential space at the 6-position of the imidazopyridine, by replacement of the bromo substituent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Random forest comparison of in vivo occupancy to in vitro parameters. (A) Relative correlation strength between occupancy at 8 h and various in vitro measurements. (B) Relative correlation strength between Occ<sub>50</sub> and various in vitro measurements.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Permeability is a key factor in determining duration of action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. More basic compounds exhibit longer duration of action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. cLogP correlates with Occ<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Calculated in vivo half-life correlates with duration of action.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Comparison of occupancy after i.t. and i.v. dosing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. (A) Efficacy of <b>25</b> (i.t.) in the rat MCT model of pulmonary hypertension in comparison to <b>1</b> (p.o.), expressed as a percentage of fully muscularised small blood vessels within the lung upon histological evaluation. (B) Efficacy of a clinically relevant dose of <b>1</b> (p.o.) in the rat MCT model of pulmonary hypertension expressed as a percentage of fully muscularised small blood vessels within the lung upon histological evaluation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Occupancy seen after inhaled dosing of <b>25</b> saccharinate salt.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/medium/jm-2016-00703y_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Kinome tree plot for <b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00703/20160901/images/large/jm-2016-00703y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00703&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ghofrani, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkins, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, S.</span><span> </span><span class="NLM_article-title">Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1201</span><span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.106.674002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1161%2FCIRCULATIONAHA.106.674002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=18779455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A280%3ADC%252BD1crptFemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=1195-1201&author=H.+A.+Ghofraniauthor=M.+W.+Wilkinsauthor=S.+Rich&title=Uncertainties+in+the+diagnosis+and+treatment+of+pulmonary+arterial+hypertension&doi=10.1161%2FCIRCULATIONAHA.106.674002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension</span></div><div class="casAuthors">Ghofrani Hossein A; Wilkins Martin W; Rich Stuart</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1195-201</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The availability of new treatments for patients with pulmonary arterial hypertension has increased awareness and interest in the medical community for pulmonary vascular diseases in general.  Many uncertainties exist, however, regarding the diagnosis and treatment of patients with pulmonary arterial hypertension that are particularly pertinent for the management of patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with underlying diseases.  This review highlights controversial issues around the definition and diagnosis of pulmonary hypertension, the interpretation of hemodynamic variables, and the interpretation of clinical responsiveness to chronic therapies.  In addition, we propose guidelines applicable to the conduct of new therapeutic trials in pulmonary arterial hypertension, which aim to provide greater confidence in the efficacy and safety of new treatments currently under development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThl754TC7ldhe4jJGKT5N0fW6udTcc2eaItxBAFKQoSbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crptFemsw%253D%253D&md5=5fc87373034ef4b670278b14afcbe8c7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.106.674002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.106.674002%26sid%3Dliteratum%253Aachs%26aulast%3DGhofrani%26aufirst%3DH.%2BA.%26aulast%3DWilkins%26aufirst%3DM.%2BW.%26aulast%3DRich%26aufirst%3DS.%26atitle%3DUncertainties%2520in%2520the%2520diagnosis%2520and%2520treatment%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DCirculation%26date%3D2008%26volume%3D118%26spage%3D1195%26epage%3D1201%26doi%3D10.1161%2FCIRCULATIONAHA.106.674002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Badesch, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champion, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez Sanchez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeper, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loyd, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGoon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeige, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olschewski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oudiz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torbicki, A.</span><span> </span><span class="NLM_article-title">Diagnosis and assessment of pulmonary arterial hypertension</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">S55</span><span class="NLM_x">–</span> <span class="NLM_lpage">S66</span><span class="refDoi"> DOI: 10.1016/j.jacc.2009.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1016%2Fj.jacc.2009.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=19555859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A280%3ADC%252BD1MvntVKiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=S55-S66&author=D.+B.+Badeschauthor=H.+C.+Championauthor=M.+A.+Gomez+Sanchezauthor=M.+M.+Hoeperauthor=J.+E.+Loydauthor=A.+Manesauthor=M.+McGoonauthor=R.+Naeigeauthor=H.+Olschewskiauthor=R.+J.+Oudizauthor=A.+Torbicki&title=Diagnosis+and+assessment+of+pulmonary+arterial+hypertension&doi=10.1016%2Fj.jacc.2009.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis and assessment of pulmonary arterial hypertension</span></div><div class="casAuthors">Badesch David B; Champion Hunter C; Sanchez Miguel Angel Gomez; Hoeper Marius M; Loyd James E; Manes Alessandra; McGoon Michael; Naeije Robert; Olschewski Horst; Oudiz Ronald J; Torbicki Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1 Suppl</span>),
    <span class="NLM_cas:pages">S55-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The diagnosis and assessment of pulmonary arterial hypertension is a rapidly evolving area, with changes occurring in the definition of the disease, screening and diagnostic techniques, and staging and follow-up assessment.  The definition of pulmonary hypertension has been simplified, and is now based on currently available evidence.  There has been substantial progress in advancing the imaging techniques and biomarkers used to screen patients for the disease and to follow up their response to therapy.  The importance of accurate assessment of right ventricular function in following up the clinical course and response to therapy is more fully appreciated.  As new therapies are developed for pulmonary arterial hypertension, screening, prompt diagnosis, and accurate assessment of disease severity become increasingly important.  A clear definition of pulmonary hypertension and the development of a rational approach to diagnostic assessment and follow-up using both conventional and new tools will be essential to deriving maximal benefit from our expanding therapeutic armamentarium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4QCMD4aslbVVwdslNBF-tfW6udTcc2ebpfQq9ZU2gYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvntVKiug%253D%253D&md5=a66a2ca93dad4e304ba226bf525e4b01</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2009.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2009.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DBadesch%26aufirst%3DD.%2BB.%26aulast%3DChampion%26aufirst%3DH.%2BC.%26aulast%3DGomez%2BSanchez%26aufirst%3DM.%2BA.%26aulast%3DHoeper%26aufirst%3DM.%2BM.%26aulast%3DLoyd%26aufirst%3DJ.%2BE.%26aulast%3DManes%26aufirst%3DA.%26aulast%3DMcGoon%26aufirst%3DM.%26aulast%3DNaeige%26aufirst%3DR.%26aulast%3DOlschewski%26aufirst%3DH.%26aulast%3DOudiz%26aufirst%3DR.%2BJ.%26aulast%3DTorbicki%26aufirst%3DA.%26atitle%3DDiagnosis%2520and%2520assessment%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2009%26volume%3D54%26spage%3DS55%26epage%3DS66%26doi%3D10.1016%2Fj.jacc.2009.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Corris, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degano, B.</span><span> </span><span class="NLM_article-title">Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation</span> <span class="citation_source-journal">Eur. Respir. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1183/09059180.00007214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1183%2F09059180.00007214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=25445947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A280%3ADC%252BC2MvmsFGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=488-497&author=P.+Corrisauthor=B.+Degano&title=Severe+pulmonary+arterial+hypertension%3A+treatment+options+and+the+bridge+to+transplantation&doi=10.1183%2F09059180.00007214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation</span></div><div class="casAuthors">Corris Paul; Degano Bruno</div><div class="citationInfo"><span class="NLM_cas:title">European respiratory review : an official journal of the European Respiratory Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">134</span>),
    <span class="NLM_cas:pages">488-97</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pulmonary arterial hypertension (PAH) is a rare disease leading to right heart failure and death.  Prognosis remains poor, particularly for patients with severe disease, i.e.  World Health Organization functional class IV.  There have been significant improvements in treatment options.  Several agents are available that target the three main established PAH disease pathways, and can be combined sequentially or upfront.  Strong scientific evidence supports the use of intravenous epoprostenol in severe PAH; however, despite recommendations, many patients do not receive parenteral prostanoids and there is a lack of evidence from randomised clinical trials supporting the value of other PAH medications alone in severe PAH.  Lung transplantation is an important option in patients with severe PAH who have not responded sufficiently to therapy, or who have worsened despite maximal treatment.  Bridging techniques are available for patients who worsen while awaiting transplantation.  The type of bridging technique used depends on various factors including patient illness severity, physician experience and the anticipated waiting time for transplantation.  With the aim to facilitate the treatment decision-making process, herein we review the medical treatment options available for patients with severe PAH, and the bridging techniques that may be used to sustain patients awaiting transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwGj4Y4FSPb691pGlMMoT5fW6udTcc2ebpfQq9ZU2gYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MvmsFGgsQ%253D%253D&md5=fde8681955f93d9ea36c2d7d4e91e7e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1183%2F09059180.00007214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09059180.00007214%26sid%3Dliteratum%253Aachs%26aulast%3DCorris%26aufirst%3DP.%26aulast%3DDegano%26aufirst%3DB.%26atitle%3DSevere%2520pulmonary%2520arterial%2520hypertension%253A%2520treatment%2520options%2520and%2520the%2520bridge%2520to%2520transplantation%26jtitle%3DEur.%2520Respir.%2520Rev.%26date%3D2014%26volume%3D23%26spage%3D488%26epage%3D497%26doi%3D10.1183%2F09059180.00007214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Perros, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorfmuller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durand-Gasselin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tcherakian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pavec, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazmanian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mussot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hervé, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emilie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddahibi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonneau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humbert, M.</span><span> </span><span class="NLM_article-title">Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1164/rccm.200707-1037OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1164%2Frccm.200707-1037OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=18420966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVWhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2008&pages=81-88&author=F.+Perrosauthor=D.+Montaniauthor=P.+Dorfmullerauthor=I.+Durand-Gasselinauthor=C.+Tcherakianauthor=J.+Le+Pavecauthor=M.+Mazmanianauthor=E.+Fadelauthor=S.+Mussotauthor=O.+Mercierauthor=P.+Herv%C3%A9author=D.+Emilieauthor=S.+Eddahibiauthor=G.+Simonneauauthor=R.+Souzaauthor=M.+Humbert&title=Platelet-derived+growth+factor+expression+and+function+in+idiopathic+pulmonary+arterial+hypertension&doi=10.1164%2Frccm.200707-1037OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension</span></div><div class="casAuthors">Perros, Frederic; Montani, David; Dorfmuller, Peter; Durand-Gasselin, Ingrid; Tcherakian, Colas; Le Pavec, Jerome; Mazmanian, Michel; Fadel, Elie; Mussot, Sacha; Mercier, Olaf; Herve, Philippe; Emilie, Dominique; Eddahibi, Saadia; Simonneau, Gerald; Souza, Rogerio; Humbert, Marc</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Platelet-derived growth factor (PDGF) promotes the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs), and may play a role in the progression of pulmonary arterial hypertension (PAH), a condition characterized by proliferation of PASMCs resulting in the obstruction of small pulmonary arteries.  Objectives: To analyze the expression and pathogenic role of PDGF in idiopathic PAH.  Methods: PDGF and PDGF receptor mRNA expression was studied by real-time reverse transcription-polymerase chain reaction performed on laser capture microdissected pulmonary arteries from patients undergoing lung transplantation for idiopathic PAH.  Immunohistochem. was used to localize PDGF, PDGF receptors, and phosphorylated PDCFR-β.  The effects of imatinib on PDGF-B-induced proliferation and chemotaxis were tested on human PASMCs.  Measurements and Main Results: PDGF-A, PDGF-B, PDGFR-α, and PDGFR-β mRNA expression was increased in small pulmonary arteries from patients displaying idiopathic PAH, as compared with control subjects.  Western blot anal. revealed a significant increase in protein expression of PDGFR-β in PAH lungs, as compared with control lungs.  In small remodeled pulmonary arteries, PDGF-A and PDGF-B mainly localized to PASMCs and endothelial cells (perivascular inflammatory infiltrates, when present, showed intensive staining), PDGFR-α and PDGFR-β mainly stained PASMCs and to a lesser extent endothelial cells.  Proliferating pulmonary vascular lesions stained phosphorylated PDGFR-β.  PDGF-BB-induced proliferation and migration of PASMCs were inhibited by imatinib.  This effect was not due to PASMC apoptosis.  Conclusions: PDGF may play an important role in human PAH.  Novel therapeutic strategies targeting the PDGF pathway should be tested in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQCTbvHzgVHLVg90H21EOLACvtfcHk0liclYOmvhY-LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVWhtL0%253D&md5=93f37eb00a8c726fd9381c8aa67117b3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1164%2Frccm.200707-1037OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200707-1037OC%26sid%3Dliteratum%253Aachs%26aulast%3DPerros%26aufirst%3DF.%26aulast%3DMontani%26aufirst%3DD.%26aulast%3DDorfmuller%26aufirst%3DP.%26aulast%3DDurand-Gasselin%26aufirst%3DI.%26aulast%3DTcherakian%26aufirst%3DC.%26aulast%3DLe%2BPavec%26aufirst%3DJ.%26aulast%3DMazmanian%26aufirst%3DM.%26aulast%3DFadel%26aufirst%3DE.%26aulast%3DMussot%26aufirst%3DS.%26aulast%3DMercier%26aufirst%3DO.%26aulast%3DHerv%25C3%25A9%26aufirst%3DP.%26aulast%3DEmilie%26aufirst%3DD.%26aulast%3DEddahibi%26aufirst%3DS.%26aulast%3DSimonneau%26aufirst%3DG.%26aulast%3DSouza%26aufirst%3DR.%26aulast%3DHumbert%26aufirst%3DM.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520expression%2520and%2520function%2520in%2520idiopathic%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2008%26volume%3D178%26spage%3D81%26epage%3D88%26doi%3D10.1164%2Frccm.200707-1037OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ghofrani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrell, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeper, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olschewski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barst, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golpon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toshner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimminger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascoe, S.</span><span> </span><span class="NLM_article-title">Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">1171</span><span class="NLM_x">–</span> <span class="NLM_lpage">1177</span><span class="refDoi"> DOI: 10.1164/rccm.201001-0123OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1164%2Frccm.201001-0123OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=20581169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFyhurbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2010&pages=1171-1177&author=A.+Ghofraniauthor=N.+W.+Morrellauthor=M.+M.+Hoeperauthor=H.+Olschewskiauthor=A.+J.+Peacockauthor=R.+J.+Barstauthor=S.+Shapiroauthor=H.+Golponauthor=M.+Toshnerauthor=F.+Grimmingerauthor=S.+Pascoe&title=Imatinib+in+pulmonary+arterial+hypertension+patients+with+inadequate+response+to+established+therapy&doi=10.1164%2Frccm.201001-0123OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy</span></div><div class="casAuthors">Ghofrani, Hossein A.; Morrell, Nicholas W.; Hoeper, Marius M.; Olschewski, Horst; Peacock, Andrew J.; Barst, Robyn J.; Shapiro, Shelley; Golpon, Heiko; Toshner, Mark; Grimminger, Friedrich; Pascoe, Steve</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1171-1177</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Pulmonary arterial hypertension (PAH) is a progressive condition with a poor prognosis.  Platelet-derived growth factor receptor (PDGFR) signaling plays an important role in its pathobiol.  Objectives: To assess safety, tolerability, and efficacy of the PDGFR inhibitor imatinib in patients with PAH.  Methods: Patients with PAH in functional classes II-IV were enrolled in a 24-wk randomized, double-blind, placebo-controlled pilot study.  Patients received imatinib (an inhibitor of PDGFR activity) 200 mg orally once daily (or placebo), which was increased to 400 mg if the initial dose was well tolerated.  The primary endpoints were safety and change from baseline in the 6-min-walk distance (6MWD).  Secondary endpoints included hemodynamics and functional classification.  Measurements and Main Results: Fifty-nine patients enrolled (imatinib [n = 28]; placebo [n = 31]); 42 completed the study.  Dropouts were equally matched between the two groups.  In the intention-to-treat (ITT) population there was no significant change in the 6MWD (mean ± SD) in the imatinib vs. placebo group (+22 ± 63 vs. -1.0 ± 53 m).  There was a significant decrease in pulmonary vascular resistance (imatinib -300 ± 347 vs. placebo -78 ± 269 dynes · s · cm-5, P < 0.01) and increase in cardiac output (imatinib +0.6 ± 1.2 vs. placebo -0.1 ± 0.9 L/min, P = 0.02).  Serious adverse events occurred in 11 imatinib recipients (39%) and 7 placebo recipients (23%).  Three deaths occurred in each group.  Post hoc subgroup analyses suggest that patients with greater hemodynamic impairment may respond better than patients with less impairment.  Conclusions: These data from a Phase II study are consistent with imatinib being well tolerated in patients with PAH, and provide proof of concept for further studies evaluating its safety, tolerability, and efficacy in PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO_t7qsxFoT7Vg90H21EOLACvtfcHk0lhz6OybV2QDUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFyhurbJ&md5=e9b087200bb9bed2266867e65841cee9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1164%2Frccm.201001-0123OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201001-0123OC%26sid%3Dliteratum%253Aachs%26aulast%3DGhofrani%26aufirst%3DA.%26aulast%3DMorrell%26aufirst%3DN.%2BW.%26aulast%3DHoeper%26aufirst%3DM.%2BM.%26aulast%3DOlschewski%26aufirst%3DH.%26aulast%3DPeacock%26aufirst%3DA.%2BJ.%26aulast%3DBarst%26aufirst%3DR.%2BJ.%26aulast%3DShapiro%26aufirst%3DS.%26aulast%3DGolpon%26aufirst%3DH.%26aulast%3DToshner%26aufirst%3DM.%26aulast%3DGrimminger%26aufirst%3DF.%26aulast%3DPascoe%26aufirst%3DS.%26atitle%3DImatinib%2520in%2520pulmonary%2520arterial%2520hypertension%2520patients%2520with%2520inadequate%2520response%2520to%2520established%2520therapy%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2010%26volume%3D182%26spage%3D1171%26epage%3D1177%26doi%3D10.1164%2Frccm.201001-0123OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Frost, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barst, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeper, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frantz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukumoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazzareno, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassoun, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klose, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrell, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peacock, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonneau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapson, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DarioVizza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felser, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, D.</span><span> </span><span class="NLM_article-title">and Ghofrani, Long-term safety and efficacy of imatinib in pulmonary arterial hypertension</span> <span class="citation_source-journal">J. Heart. Lung. Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1366</span><span class="NLM_x">–</span> <span class="NLM_lpage">1375</span><span class="refDoi"> DOI: 10.1016/j.healun.2015.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1016%2Fj.healun.2015.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=26210752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FmsVyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1366-1375&author=A.+E.+Frostauthor=R.+J.+Barstauthor=M.+M.+Hoeperauthor=H.-J.+Changauthor=R.+P.+Frantzauthor=Y.+Fukumotoauthor=G.+N.+Nazzarenoauthor=P.+M.+Hassounauthor=H.+Kloseauthor=H.+Matsubaraauthor=N.+W.+Morrellauthor=A.+J.+Peacockauthor=M.+Pfeiferauthor=G.+Simonneauauthor=V.+F.+Tapsonauthor=F.+Torresauthor=C.+DarioVizzaauthor=D.+Lawrenceauthor=W.+Yangauthor=J.+M.+Felserauthor=D.+Quinn&title=and+Ghofrani%2C+Long-term+safety+and+efficacy+of+imatinib+in+pulmonary+arterial+hypertension&doi=10.1016%2Fj.healun.2015.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term safety and efficacy of imatinib in pulmonary arterial hypertension</span></div><div class="casAuthors">Frost Adaani E; Barst Robyn J; Hoeper Marius M; Chang Hyuk-Jae; Frantz Robert P; Fukumoto Yoshihiro; Galie Nazzareno; Hassoun Paul M; Klose Hans; Matsubara Hiromi; Morrell Nicholas W; Peacock Andrew J; Pfeifer Michael; Simonneau Gerald; Tapson Victor F; Torres Fernando; Dario Vizza Carmine; Lawrence David; Yang Wei; Felser James M; Quinn Deborah A; Ghofrani Hossein-Ardeschir</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1366-75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Imatinib is an oral inhibitor of several protein kinases implicated in the pathophysiology of pulmonary hypertension.  Treatment with imatinib resulted in improved hemodynamics and exercise capacity in a controlled trial (Imatinib [QTI571] in Pulmonary Arterial Hypertension, a Randomized Efficacy Study [IMPRES]), among pulmonary arterial hypertension (PAH) patients inadequately responsive to 2 to 3 PAH-specific therapies.  METHODS:  The long-term (up to 204 weeks) safety and efficacy of imatinib in this open-label extension study were reviewed until early study termination on April 16, 2014.  Of 202 IMPRES-enrolled patients, 66 imatinib and 78 placebo recipients entered the extension.  RESULTS:  Overall, 93.8% (135 of 144) of patients discontinued the extension study; administrative issues (i.e., sponsor termination; 32.6%) and adverse events (31.3%) were the primary reasons for discontinuation.  Nine patients completed the extension study before it was terminated.  Serious and unexpected adverse events were frequent.  These included 6 subdural hematomas in the extension study and 17 deaths during or within 30 days of study end.  Although the patients who tolerated imatinib and remained in the extension for a longer duration did experience an improvement in functional class and walk distance, most discontinued the drug and the study.  CONCLUSIONS:  Severe adverse events, significant side effects, and a high discontinuation rate limit the utility of imatinib in the treatment of PAH.  These risks outweigh any possible improvements in hemodynamics and walk distance seen in those patients able to remain on drug.  The off-label use of this compound in PAH is discouraged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2vWkaw12dnszK395ZObgVfW6udTcc2eYZXHgSHRp2a7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FmsVyjsA%253D%253D&md5=d4af0c5c1450214dfc06dfc3e1702e11</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.healun.2015.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.healun.2015.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DA.%2BE.%26aulast%3DBarst%26aufirst%3DR.%2BJ.%26aulast%3DHoeper%26aufirst%3DM.%2BM.%26aulast%3DChang%26aufirst%3DH.-J.%26aulast%3DFrantz%26aufirst%3DR.%2BP.%26aulast%3DFukumoto%26aufirst%3DY.%26aulast%3DNazzareno%26aufirst%3DG.%2BN.%26aulast%3DHassoun%26aufirst%3DP.%2BM.%26aulast%3DKlose%26aufirst%3DH.%26aulast%3DMatsubara%26aufirst%3DH.%26aulast%3DMorrell%26aufirst%3DN.%2BW.%26aulast%3DPeacock%26aufirst%3DA.%2BJ.%26aulast%3DPfeifer%26aufirst%3DM.%26aulast%3DSimonneau%26aufirst%3DG.%26aulast%3DTapson%26aufirst%3DV.%2BF.%26aulast%3DTorres%26aufirst%3DF.%26aulast%3DDarioVizza%26aufirst%3DC.%26aulast%3DLawrence%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DFelser%26aufirst%3DJ.%2BM.%26aulast%3DQuinn%26aufirst%3DD.%26atitle%3Dand%2520Ghofrani%252C%2520Long-term%2520safety%2520and%2520efficacy%2520of%2520imatinib%2520in%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DJ.%2520Heart.%2520Lung.%2520Transplant.%26date%3D2015%26volume%3D34%26spage%3D1366%26epage%3D1375%26doi%3D10.1016%2Fj.healun.2015.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7A"><span><span class="NLM_label">(A) </span><span class="NLM_contrib-group">Cooper, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span> </span><span class="NLM_article-title">Optimisation of DMPK by the inhaled route: challenges and approaches</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span><span class="refDoi"> DOI: 10.2174/138920012800166571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7A&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.2174%2F138920012800166571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7A&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=22299825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7A&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=457-473&author=E.+A.+Cooperauthor=D.+Fergusonauthor=K.+Grime&title=Optimisation+of+DMPK+by+the+inhaled+route%3A+challenges+and+approaches&doi=10.2174%2F138920012800166571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7AR"><div class="casContent"><span class="casTitleNuber">7A</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of DMPK by the inhaled route: challenges and approaches</span></div><div class="casAuthors">Cooper, Anne E.; Ferguson, Douglas; Grime, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-473</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in inhalation delivery over recent years has led to an expansion in the understanding of lung pharmacokinetics.  Historically optimization of inhaled drugs focused largely on development of material properties, consistent with achieving a good lung deposition, alongside demonstrating appropriate in vivo efficacy with little understanding of the relationship to pharmacokinetics in the lung.  Recent efforts have led to an increased understanding of lung concns. and how to maximize exposure to achieve the desired pharmacol. response at a dose consistent with development of an inhaled product.  Although there is a prerequisite for excellent potency in inhalation delivery, it is essential that this be combined with pharmacokinetic properties that allow sufficient free concn. at the effect site in lung to exert the pharmacol. response for an appropriate dosing interval.  Increases in basicity, polarity and/or decreases in aq. soly. can extend pharmacokinetic duration and assist in finding the right balance between lung and systemic exposure.  Current evidence suggests there are similarities in lung retention in rat and dog and that animal lung concn. data can enable pharmacokinetic-pharmacodynamic relationships to be derived thus providing more confidence in the requirements for man.  Although inhaled delivery is challenging from a pharmacokinetic point of view, direct evaluation of exposure in the target organ has enabled further understanding of the drivers for drug disposition and highlighted the need for further development of predictive lung pharmacokinetic tools in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxztkVtHyCeLVg90H21EOLACvtfcHk0li9PQnjWbV6Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVeitbg%253D&md5=1dec4f52aeda55fe6ea888c289216d94</span></div><a href="/servlet/linkout?suffix=cit7A&amp;dbid=16384&amp;doi=10.2174%2F138920012800166571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920012800166571%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DE.%2BA.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DGrime%26aufirst%3DK.%26atitle%3DOptimisation%2520of%2520DMPK%2520by%2520the%2520inhaled%2520route%253A%2520challenges%2520and%2520approaches%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2012%26volume%3D13%26spage%3D457%26epage%3D473%26doi%3D10.2174%2F138920012800166571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7B"><span><span class="NLM_label">(B) </span><span class="NLM_contrib-group">Tronde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lennernäs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, U.</span><span> </span><span class="NLM_article-title">Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1216</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span><span class="refDoi"> DOI: 10.1002/jps.10386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7B&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1002%2Fjps.10386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7B&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=12761811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7B&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD3sXks1KisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=1216-1233&author=A.+Trondeauthor=B.+Nordenauthor=H.+Marchnerauthor=A.+Wendelauthor=H.+Lennern%C3%A4sauthor=U.+Bengtsson&title=Pulmonary+absorption+rate+and+bioavailability+of+drugs+in+vivo+in+rats%3A+structure-absorption+relationships+and+physicochemical+profiling+of+inhaled+drugs&doi=10.1002%2Fjps.10386"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7BR"><div class="casContent"><span class="casTitleNuber">7B</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary absorption rate and bioavailability of drugs in vivo in rats: Structure-absorption relationships and physicochemical profiling of inhaled drugs</span></div><div class="casAuthors">Tronde, Ann; Norden, Bo; Marchner, Hans; Wendel, Anna-Karin; Lennernaes, Hans; Bengtsson, Ursula Hultkvist</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1216-1233</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The aim of this investigation was to analyze the structure-absorption relationships for pulmonary delivered drugs.  First, the inhaled drugs on the market during 2001 were identified and a profile of the calcd. physicochem. properties was made.  Second, an in vivo pharmacokinetic investigation was performed in anesthetized rats.  Eight selected drugs were administered by intratracheal nebulization and i.v. bolus administration and the plasma concns. of the drugs were detd. by LC-MS-MS.  Third, an evaluation of the relationships between the absorption/bioavailability data and the drugs' physicochem. characteristics and the epithelial permeability in Caco-2 cells, resp., was performed.  The drug absorption rate was found to correlate to the mol. polar surface area and the hydrogen bonding potential, as well as to the apparent permeability in Caco-2 cell monolayers, which indicated that passive diffusion was the predominating mechanism of absorption in the rat lung.  In contrast to the intestinal mucosa and the blood-brain barrier, the pulmonary epithelium was shown to be highly permeable to compds. with high mol. polar surface area (e.g., PSA 479 Å2).  Furthermore, a high bioavailability was found for the efflux transporter substrates talinolol (81%) and losartan (92%), which provides functional evidence for a quant. less important role for efflux transporters, such as P-glycoprotein, in limiting the absorption of these drugs from the rat lung.  In conclusion, the pulmonary route should be regarded as a potential alternative for the delivery of drugs that are inadequately absorbed after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-H1jPkrdCM7Vg90H21EOLACvtfcHk0li9PQnjWbV6Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXks1KisLY%253D&md5=ab6a275a5ec7cf2cfad3aff031a87fab</span></div><a href="/servlet/linkout?suffix=cit7B&amp;dbid=16384&amp;doi=10.1002%2Fjps.10386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10386%26sid%3Dliteratum%253Aachs%26aulast%3DTronde%26aufirst%3DA.%26aulast%3DNorden%26aufirst%3DB.%26aulast%3DMarchner%26aufirst%3DH.%26aulast%3DWendel%26aufirst%3DA.%26aulast%3DLennern%25C3%25A4s%26aufirst%3DH.%26aulast%3DBengtsson%26aufirst%3DU.%26atitle%3DPulmonary%2520absorption%2520rate%2520and%2520bioavailability%2520of%2520drugs%2520in%2520vivo%2520in%2520rats%253A%2520structure-absorption%2520relationships%2520and%2520physicochemical%2520profiling%2520of%2520inhaled%2520drugs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D1216%26epage%3D1233%26doi%3D10.1002%2Fjps.10386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Cazzola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calzetta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, M. G.</span><span> </span><span class="NLM_article-title">Pharmacology and therapeutics of bronchodilators</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1124/pr.111.004580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1124%2Fpr.111.004580" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=450-504&author=M.+Cazzolaauthor=C.+P.+Pageauthor=L.+Calzettaauthor=M.+G.+Matera&title=Pharmacology+and+therapeutics+of+bronchodilators&doi=10.1124%2Fpr.111.004580"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fpr.111.004580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.111.004580%26sid%3Dliteratum%253Aachs%26aulast%3DCazzola%26aufirst%3DM.%26aulast%3DPage%26aufirst%3DC.%2BP.%26aulast%3DCalzetta%26aufirst%3DL.%26aulast%3DMatera%26aufirst%3DM.%2BG.%26atitle%3DPharmacology%2520and%2520therapeutics%2520of%2520bronchodilators%26jtitle%3DPharmacol.%2520Rev.%26date%3D2012%26volume%3D64%26spage%3D450%26epage%3D504%26doi%3D10.1124%2Fpr.111.004580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheibe, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. P.</span><span> </span><span class="NLM_article-title">Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">31655</span><span class="NLM_x">–</span> <span class="NLM_lpage">31663</span><span class="refDoi"> DOI: 10.1074/jbc.M403319200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1074%2Fjbc.M403319200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=15123710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslOrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=31655-31663&author=C.+D.+Molauthor=D.+R.+Douganauthor=T.+R.+Schneiderauthor=R.+J.+Skeneauthor=M.+L.+Krausauthor=D.+N.+Scheibeauthor=G.+P.+Snellauthor=H.+Zouauthor=B.+C.+Sangauthor=K.+P.+Wilson&title=Structural+basis+for+the+autoinhibition+and+STI-571+inhibition+of+c-Kit+tyrosine+kinase&doi=10.1074%2Fjbc.M403319200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase</span></div><div class="casAuthors">Mol, Clifford D.; Dougan, Douglas R.; Schneider, Thomas R.; Skene, Robert J.; Kraus, Michelle L.; Scheibe, Daniel N.; Snell, Gyorgy P.; Zou, Hua; Sang, Bi-Ching; Wilson, Keith P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">31655-31663</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activity of the c-Kit receptor protein-tyrosine kinase is tightly regulated in normal cells, whereas deregulated c-Kit kinase activity is implicated in the pathogenesis of human cancers.  The c-Kit juxtamembrane region is known to have an autoinhibitory function; however the precise mechanism by which c-Kit is maintained in an autoinhibited state is not known.  We report the 1.9-Å resoln. crystal structure of native c-Kit kinase in an autoinhibited conformation and compare it with active c-Kit kinase.  Autoinhibited c-Kit is stabilized by the juxtamembrane domain, which inserts into the kinase-active site and disrupts formation of the activated structure.  A 1.6-Å crystal structure of c-Kit in complex with STI-571 (Imatinib or Gleevec) demonstrates that inhibitor binding disrupts this natural mechanism for maintaining c-Kit in an autoinhibited state.  Together, these results provide a structural basis for understanding c-Kit kinase autoinhibition and will facilitate the structure-guided design of specific inhibitors that target the activated and autoinhibited conformations of c-Kit kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWJsKx1IzXQbVg90H21EOLACvtfcHk0li9PQnjWbV6Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslOrtrc%253D&md5=df6065a62b44e4c2e6b020da0f797ab4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M403319200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M403319200%26sid%3Dliteratum%253Aachs%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DScheibe%26aufirst%3DD.%2BN.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DWilson%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520autoinhibition%2520and%2520STI-571%2520inhibition%2520of%2520c-Kit%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D31655%26epage%3D31663%26doi%3D10.1074%2Fjbc.M403319200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bruce, I.; Chamoin, S.; Collingwood, S. P.; Furet, P.; Furminger, V.; Lewis, S.; Loren, J. C.; Molteni, V.; Saunders, A. M.; Shaw, D.; Sviridenko, L.; Thomson, C.; Yeh, V.; Janus, D.; West, R.</span><span> </span><span class="NLM_article-title">Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension</span>. Patent WO2013030802, March 7, 2013.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bruce%2C+I.%3B+Chamoin%2C+S.%3B+Collingwood%2C+S.+P.%3B+Furet%2C+P.%3B+Furminger%2C+V.%3B+Lewis%2C+S.%3B+Loren%2C+J.+C.%3B+Molteni%2C+V.%3B+Saunders%2C+A.+M.%3B+Shaw%2C+D.%3B+Sviridenko%2C+L.%3B+Thomson%2C+C.%3B+Yeh%2C+V.%3B+Janus%2C+D.%3B+West%2C+R.+Bicyclic+heterocycle+derivatives+for+the+treatment+of+pulmonary+arterial+hypertension.+Patent+WO2013030802%2C+March+7%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBruce%26aufirst%3DI.%26atitle%3DBicyclic%2520heterocycle%2520derivatives%2520for%2520the%2520treatment%2520of%2520pulmonary%2520arterial%2520hypertension" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="note"><p class="first last">Average of <i>N</i> = 3 test occasions. The effect of the test compound on the phosphorylation of a probe peptide substrate by PDGFRα was measured via capillary electrophoresis on a Caliper Labchip 3000 machine. The measurements could be used to determine an IC<sub>50</sub> in a high throughput manner</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">Average of <i>N</i> = 3 test occasions. For full procedure refer to the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf" class="ext-link">Supporting Information</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">%Transcellular readings from the PAMPA assay were used as an increased resolution was seen at very low permeability rates by using this parameter.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">DeSimone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darrow, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span> </span><span class="NLM_article-title">Privileged structures: applications in drug discovery</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.2174/1386207043328544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.2174%2F1386207043328544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=15320713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFegsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=473-494&author=R.+W.+DeSimoneauthor=K.+S.+Currieauthor=S.+A.+Mitchellauthor=J.+W.+Darrowauthor=D.+A.+Pippin&title=Privileged+structures%3A+applications+in+drug+discovery&doi=10.2174%2F1386207043328544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged structures: Applications in drug discovery</span></div><div class="casAuthors">DeSimone, R. W.; Currie, K. S.; Mitchell, S. A.; Darrow, J. W.; Pippin, D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">473-493</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past 15 yr the privileged structure concept has emerged as a fruitful approach to the discovery of novel biol. active mols.  Privileged structures are mol. scaffolds with versatile binding properties, such that a single scaffold is able to provide potent and selective ligands for a range of different biol. targets through modification of functional groups.  In addn., privileged structures typically exhibit good drug-like properties, which in turn leads to more drug-like compd. libraries and leads.  The net result is the prodn. of high quality leads that provide a solid foundation for further development.  The identification of privileged structures will be discussed, emphasizing the importance of understanding the structure-target relationships that confer "privileged" status.  This understanding allows privileged structure based libraries to be targeted at distinct target families (e.g. GPCRs, LGIC, enzymes/kinases).  Privileged structures have been successfully exploited across and within different target families and promises to be an effective approach to the discovery and optimization of novel bioactive mols.  The application of the privileged structure approach, both in traditional medicinal chem. and in the design of focused libraries, will be discussed with the aid of illustrative examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIDSZoRtfibVg90H21EOLACvtfcHk0ljubAtr5h-n8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFegsrY%253D&md5=165b976f9d6c6d38d752cabf2c647a48</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1386207043328544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207043328544%26sid%3Dliteratum%253Aachs%26aulast%3DDeSimone%26aufirst%3DR.%2BW.%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26aulast%3DDarrow%26aufirst%3DJ.%2BW.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26atitle%3DPrivileged%2520structures%253A%2520applications%2520in%2520drug%2520discovery%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2004%26volume%3D7%26spage%3D473%26epage%3D494%26doi%3D10.2174%2F1386207043328544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Valko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, M. H.</span><span> </span><span class="NLM_article-title">Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">–</span> <span class="NLM_lpage">1096</span><span class="refDoi"> DOI: 10.1002/1520-6017(200008)89:8<1085::AID-JPS13>3.0.CO;2-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1002%2F1520-6017%28200008%2989%3A8%3C1085%3A%3AAID-JPS13%3E3.0.CO%3B2-N" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2000&pages=1085-1096&author=K.+Valkoauthor=C.+M.+Duauthor=C.+D.+Bevanauthor=D.+P.+Reynoldsauthor=M.+H.+Abraham&title=Rapid-gradient+HPLC+method+for+measuring+drug+interactions+with+immobilized+artificial+membrane%3A+comparison+with+other+lipophilicity+measures&doi=10.1002%2F1520-6017%28200008%2989%3A8%3C1085%3A%3AAID-JPS13%3E3.0.CO%3B2-N"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2F1520-6017%28200008%2989%3A8%3C1085%3A%3AAID-JPS13%3E3.0.CO%3B2-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1520-6017%2528200008%252989%253A8%253C1085%253A%253AAID-JPS13%253E3.0.CO%253B2-N%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DDu%26aufirst%3DC.%2BM.%26aulast%3DBevan%26aufirst%3DC.%2BD.%26aulast%3DReynolds%26aufirst%3DD.%2BP.%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26atitle%3DRapid-gradient%2520HPLC%2520method%2520for%2520measuring%2520drug%2520interactions%2520with%2520immobilized%2520artificial%2520membrane%253A%2520comparison%2520with%2520other%2520lipophilicity%2520measures%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D89%26spage%3D1085%26epage%3D1096%26doi%3D10.1002%2F1520-6017%28200008%2989%3A8%3C1085%3A%3AAID-JPS13%3E3.0.CO%3B2-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mallik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briscoe, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hage, D. S.</span><span> </span><span class="NLM_article-title">Analysis of drug-protein binding by ultra fast affinity chromatography using immobilized human serum albumin</span> <span class="citation_source-journal">J. Chromatogr. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1217</span><span class="NLM_x">, </span> <span class="NLM_fpage">2796</span><span class="NLM_x">–</span> <span class="NLM_lpage">2803</span><span class="refDoi"> DOI: 10.1016/j.chroma.2010.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1016%2Fj.chroma.2010.02.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1217&publication_year=2010&pages=2796-2803&author=R.+Mallikauthor=M.+J.+Yooauthor=C.+J.+Briscoeauthor=D.+S.+Hage&title=Analysis+of+drug-protein+binding+by+ultra+fast+affinity+chromatography+using+immobilized+human+serum+albumin&doi=10.1016%2Fj.chroma.2010.02.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2010.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2010.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DMallik%26aufirst%3DR.%26aulast%3DYoo%26aufirst%3DM.%2BJ.%26aulast%3DBriscoe%26aufirst%3DC.%2BJ.%26aulast%3DHage%26aufirst%3DD.%2BS.%26atitle%3DAnalysis%2520of%2520drug-protein%2520binding%2520by%2520ultra%2520fast%2520affinity%2520chromatography%2520using%2520immobilized%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D2010%26volume%3D1217%26spage%3D2796%26epage%3D2803%26doi%3D10.1016%2Fj.chroma.2010.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etheridge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. A.</span><span> </span><span class="NLM_article-title">Studies in drug albumin binding using HSA and RSA affinity methods</span> <span class="citation_source-journal">J. Liq. Chromatogr. Relat. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1080/10826076.2011.548299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1080%2F10826076.2011.548299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVShtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=317-327&author=J.+Reillyauthor=D.+Etheridgeauthor=B.+Everattauthor=Z.+Jiangauthor=C.+Springerauthor=R.+A.+Fairhurst&title=Studies+in+drug+albumin+binding+using+HSA+and+RSA+affinity+methods&doi=10.1080%2F10826076.2011.548299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Studies in drug albumin binding using HSA and RSA affinity methods</span></div><div class="casAuthors">Reilly, John; Etheridge, Donnya; Everatt, Brian; Jiang, Zheng-jin; Aldcroft, Clive; Wright, Penny; Clemens, Ian; Cox, Brian; Press, Neil J.; Watson, Simon; Porter, David; Springer, Clayton; Fairhurst, Robin A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liquid Chromatography & Related Technologies</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">317-327</span>CODEN:
                <span class="NLM_cas:coden">JLCTFC</span>;
        ISSN:<span class="NLM_cas:issn">1082-6076</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A HPLC gradient methodol. using immobilized human serum albumin (HSA) and rat serum albumin (RSA) has been used as a tool to investigate the protein binding trends of novel discovery compds.  These methods have been set up to support a high throughput approach and have been shown to be complementary to one another.  Significant binding differences have been obsd. with some compds. when both methods have been employed.  Discovery chemists are now also able to rank order mols. using these quick "trend anal." albumin binding screens by submitting a 20 μl sample from the 10 mM stock soln. from the inhouse compd. archive.  Addnl., chemists have the opportunity to predict trends in albumin binding by use of an internal QSAR model based upon a diverse 1200 compd. result set, which had been previously analyzed with the HSA methodol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3I_bdVVhi6rVg90H21EOLACvtfcHk0lgz4BDgzA-9eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVShtbo%253D&md5=519ddd9fc72d2e8c6f16fbc79c4c3fcb</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1080%2F10826076.2011.548299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10826076.2011.548299%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DEtheridge%26aufirst%3DD.%26aulast%3DEveratt%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DFairhurst%26aufirst%3DR.%2BA.%26atitle%3DStudies%2520in%2520drug%2520albumin%2520binding%2520using%2520HSA%2520and%2520RSA%2520affinity%2520methods%26jtitle%3DJ.%2520Liq.%2520Chromatogr.%2520Relat.%2520Technol.%26date%3D2011%26volume%3D34%26spage%3D317%26epage%3D327%26doi%3D10.1080%2F10826076.2011.548299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">Details of occupancy assay are in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf" class="ext-link">Supporting Information</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">Database of in vitro and in silico properties of the compounds tesed in vivo is part of the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span>Supplied by Cell Signaling Technology (<a href="http://www.cellsignal.com" class="extLink">www.cellsignal.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Supplied+by+Cell+Signaling+Technology+%28www.cellsignal.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hollósy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valkó, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunhuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kéri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, C.</span><span> </span><span class="NLM_article-title">Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6958</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1021/jm050957i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050957i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ClurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6958-71&author=F.+Holl%C3%B3syauthor=K.+Valk%C3%B3author=A.+Herseyauthor=S.+Nunhuckauthor=G.+K%C3%A9riauthor=C.+Bevan&title=Estimation+of+volume+of+distribution+in+humans+from+high+throughput+HPLC-based+measurements+of+human+serum+albumin+binding+and+immobilized+artificial+membrane+partitioning&doi=10.1021%2Fjm050957i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of Volume of Distribution in Humans from High Throughput HPLC-Based Measurements of Human Serum Albumin Binding and Immobilized Artificial Membrane Partitioning</span></div><div class="casAuthors">Hollosy, Ferenc; Valko, Klara; Hersey, Anne; Nunhuck, Shenaz; Keri, Gyoergy; Bevan, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6958-6971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The vol. of distribution (VD) in humans of 179 known drug mols. (acids, bases, and neutrals) has been modeled using two biomimetic-binding measurements.  The phospholipid binding (log K (IAM)) and the plasma protein binding (log K (HSA)) have been calcd. from gradient HPLC retention times on immobilized artificial membrane (IAM) and on human serum albumin (HSA) columns, resp.  The log VD values showed good correlation with the compds.' relative binding to IAM and HSA as follows: log VD = 0.44 log K (IAM) - 0.22 log K (HSA) - 0.66; n = 179, r2 = 0.76, s = 0.33, and F = 272.  It was also obsd. that pos. charged mols. bind relatively more to IAM, while neg. charged ones bind more to HSA, in line with the empirical observation that bases tend to have a larger vol. of distribution than acids.  These results suggest that with the help of these two simple high throughput HPLC-based biomimetic binding measurements an important in vivo drug disposition property can be estd. for use in early drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBHWlrSQHQUbVg90H21EOLACvtfcHk0lgz4BDgzA-9eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ClurfK&md5=e19a0a058e052287cdca97c2125f9da4</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm050957i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050957i%26sid%3Dliteratum%253Aachs%26aulast%3DHoll%25C3%25B3sy%26aufirst%3DF.%26aulast%3DValk%25C3%25B3%26aufirst%3DK.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DK%25C3%25A9ri%26aufirst%3DG.%26aulast%3DBevan%26aufirst%3DC.%26atitle%3DEstimation%2520of%2520volume%2520of%2520distribution%2520in%2520humans%2520from%2520high%2520throughput%2520HPLC-based%2520measurements%2520of%2520human%2520serum%2520albumin%2520binding%2520and%2520immobilized%2520artificial%2520membrane%2520partitioning%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6958%26epage%3D71%26doi%3D10.1021%2Fjm050957i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jones, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loscalzo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Y.</span><span> </span><span class="NLM_article-title">Serial noninvasive assessment of progressive pulmonary hypertension in a rat model</span> <span class="citation_source-journal">Am. J. Physiol. Heart Circ. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">H364</span><span class="NLM_x">–</span> <span class="NLM_lpage">H371</span><span class="refDoi"> DOI: 10.1152/ajpheart.00979.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1152%2Fajpheart.00979.2001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2002&pages=H364-H371&author=J.+E.+Jonesauthor=L.+Mendesauthor=M.+A.+Ruddauthor=G.+Russoauthor=J.+Loscalzoauthor=Y.-Y.+Zhang&title=Serial+noninvasive+assessment+of+progressive+pulmonary+hypertension+in+a+rat+model&doi=10.1152%2Fajpheart.00979.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00979.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00979.2001%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DJ.%2BE.%26aulast%3DMendes%26aufirst%3DL.%26aulast%3DRudd%26aufirst%3DM.%2BA.%26aulast%3DRusso%26aufirst%3DG.%26aulast%3DLoscalzo%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.-Y.%26atitle%3DSerial%2520noninvasive%2520assessment%2520of%2520progressive%2520pulmonary%2520hypertension%2520in%2520a%2520rat%2520model%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2002%26volume%3D283%26spage%3DH364%26epage%3DH371%26doi%3D10.1152%2Fajpheart.00979.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gomez-Arroyo, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farkas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhussaini, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farkas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraskauskas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voelkel, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogaard, H. J.</span><span> </span><span class="NLM_article-title">The monocrotaline model of pulmonary hypertension in perspective</span> <span class="citation_source-journal">Am. J. Physiol. Lung Cell Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">L363</span><span class="NLM_x">–</span> <span class="NLM_lpage">L369</span><span class="refDoi"> DOI: 10.1152/ajplung.00212.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1152%2Fajplung.00212.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=21964406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFKns78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2012&pages=L363-L369&author=J.+G.+Gomez-Arroyoauthor=L.+Farkasauthor=A.+A.+Alhussainiauthor=D.+Farkasauthor=D.+Kraskauskasauthor=N.+F.+Voelkelauthor=H.+J.+Bogaard&title=The+monocrotaline+model+of+pulmonary+hypertension+in+perspective&doi=10.1152%2Fajplung.00212.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">The monocrotaline model of pulmonary hypertension in perspective</span></div><div class="casAuthors">Gomez-Arroyo, Jose G.; Farkas, Laszlo; Alhussaini, Aysar A.; Farkas, Daniela; Kraskauskas, Donatas; Voelkel, Norbert F.; Bogaard, Harm J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">L363-L369</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Severe forms of pulmonary arterial hypertension (PAH) are characterized by various degrees of remodeling of the pulmonary arterial vessels, which increases the pulmonary vascular resistance and right ventricular afterload, thus contributing to the development of right ventricle dysfunction and failure.  Recent years have seen advances in the understanding of the pathobiol. of PAH; however, many important questions remain unanswered.  Elucidating the pathobiol. of PAH continues to be crit. to design new effective therapeutic strategies, and appropriate animal models of PAH are necessary to achieve the task.  Although the monocrotaline rat model of PAH has contributed to a better understanding of vascular remodeling in pulmonary hypertension, we question the validity of this model as a preclinically relevant model of severe plexogenic PAH.  Here we review pertinent publications that either have been forgotten or ignored, and we reexamine the monocrotaline model in the context of human forms of PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfhQAJlfdHW7Vg90H21EOLACvtfcHk0lh-zDrBWfjeNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFKns78%253D&md5=bc1f51b0ed2a5a71e02974c1e51a0474</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00212.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00212.2011%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Arroyo%26aufirst%3DJ.%2BG.%26aulast%3DFarkas%26aufirst%3DL.%26aulast%3DAlhussaini%26aufirst%3DA.%2BA.%26aulast%3DFarkas%26aufirst%3DD.%26aulast%3DKraskauskas%26aufirst%3DD.%26aulast%3DVoelkel%26aufirst%3DN.%2BF.%26aulast%3DBogaard%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520monocrotaline%2520model%2520of%2520pulmonary%2520hypertension%2520in%2520perspective%26jtitle%3DAm.%2520J.%2520Physiol.%2520Lung%2520Cell%2520Mol.%2520Physiol.%26date%3D2012%26volume%3D302%26spage%3DL363%26epage%3DL369%26doi%3D10.1152%2Fajplung.00212.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Stenmark, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurtry, I. F.</span><span> </span><span class="NLM_article-title">Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure</span> <span class="citation_source-journal">Am. J. Physiol. Lung Cell Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">L1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">L1032</span><span class="refDoi"> DOI: 10.1152/ajplung.00217.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1152%2Fajplung.00217.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=19748998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOgtr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=L1013-L1032&author=K.+R.+Stenmarkauthor=B.+Meyrickauthor=N.+Galieauthor=W.+J.+Mooiauthor=I.+F.+McMurtry&title=Animal+models+of+pulmonary+arterial+hypertension%3A+the+hope+for+etiological+discovery+and+pharmacological+cure&doi=10.1152%2Fajplung.00217.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure</span></div><div class="casAuthors">Stenmark, Kurt R.; Meyrick, Barbara; Galie, Nazzareno; Mooi, Wolter J.; McMurtry, Ivan F.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">6, Pt. 1</span>),
    <span class="NLM_cas:pages">L1013-L1032</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  At present, six groups of chronic pulmonary hypertension (PH) are described.  Among these, group 1 (and 1') comprises a group of diverse diseases termed pulmonary arterial hypertension (PAH) that have several pathophysiol., histol., and prognostic features in common.  PAH is a particularly severe and progressive form of PH that frequently leads to right heart failure and premature death.  The diagnosis of PAH must include a series of defined clin. parameters, which extend beyond mere elevations in pulmonary arterial pressures and include precapillary PH, pulmonary hypertensive arteriopathy (usually with plexiform lesions), slow clin. onset (months or years), and a chronic time course (years) characterized by progressive deterioration.  What appears to distinguish PAH from other forms of PH is the severity of the arteriopathy obsd., the defining characteristic of which is "plexogenic arteriopathy.".  The pathogenesis of this arteriopathy remains unclear despite intense investigation in a variety of animal model systems.  The most commonly used animal models ("classic" models) are rodents exposed to either hypoxia or monocrotaline.  Newer models, which involve modification of classic approaches, have been developed that exhibit more severe PH and vascular lesions, which include neointimal proliferation and occlusion of small vessels.  In addn., genetically manipulated mice have been generated that have provided insight into the role of specific mols. in the pulmonary hypertensive process.  Unfortunately, at present, there is no perfect preclin. model that completely recapitulates human PAH.  All models, however, have provided and will continue to provide invaluable insight into the numerous pathways that contribute to the development and maintenance of PH.  Use of both classic and newly developed animal models will allow continued rigorous testing of new hypotheses regarding pathogenesis and treatment.  This review highlights progress that has been made in animal modeling of this important human condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQp6B2ETV6lbVg90H21EOLACvtfcHk0lh-zDrBWfjeNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOgtr%252FO&md5=8ba257a084e50c70e2d73cb3bdff0655</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00217.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00217.2009%26sid%3Dliteratum%253Aachs%26aulast%3DStenmark%26aufirst%3DK.%2BR.%26aulast%3DMeyrick%26aufirst%3DB.%26aulast%3DGalie%26aufirst%3DN.%26aulast%3DMooi%26aufirst%3DW.%2BJ.%26aulast%3DMcMurtry%26aufirst%3DI.%2BF.%26atitle%3DAnimal%2520models%2520of%2520pulmonary%2520arterial%2520hypertension%253A%2520the%2520hope%2520for%2520etiological%2520discovery%2520and%2520pharmacological%2520cure%26jtitle%3DAm.%2520J.%2520Physiol.%2520Lung%2520Cell%2520Mol.%2520Physiol.%26date%3D2009%26volume%3D297%26spage%3DL1013%26epage%3DL1032%26doi%3D10.1152%2Fajplung.00217.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Bruce, I.; Chamoin, S.; Furet, P.; Furminger, V.; Lewis, S.; Loren, J.; Lin, L. V.; Molteni, V.; Saunders, A. M.; Shaw, D. E.; Turner, R.; Yeh, V.</span><span class="NLM_x"> (</span><span class="NLM_year">2014</span><span class="NLM_x">) </span><span> </span><span class="NLM_article-title">Solid forms of bicyclic heterocyclic derivatives as pdgf receptor mediators</span>. Patent WO2014132220, September 4, 2014.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=I.+Bruce&author=S.+Chamoin&author=P.+Furet&author=V.+Furminger&author=S.+Lewis&author=J.+Loren&author=L.+V.+Lin&author=V.+Molteni&author=A.+M.+Saunders&author=D.+E.+Shaw&author=R.+Turner&author=V.+Yeh&title=Solid+forms+of+bicyclic+heterocyclic+derivatives+as+pdgf+receptor+mediators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBruce%26aufirst%3DI.%26date%3D2014%26atitle%3DSolid%2520forms%2520of%2520bicyclic%2520heterocyclic%2520derivatives%2520as%2520pdgf%2520receptor%2520mediators" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span><span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lh-zDrBWfjeNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=IT46" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=IT46','PDB','IT46'); return false;">PDB: IT46</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T46','PDB','1T46'); return false;">PDB: 1T46</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i30"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00703">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_44783"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00703">10.1021/acs.jmedchem.6b00703</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures for cell-based assay/occupancy assay; statistical test details (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf">PDF</a>)</p></li><li><p class="inline">In vitro:in vivo correlation data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_002.csv">CSV</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_001.pdf">jm6b00703_si_001.pdf (132.57 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_002.csv">jm6b00703_si_002.csv (5.81 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00703/suppl_file/jm6b00703_si_003.csv">jm6b00703_si_003.csv (1.5 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00703&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00703%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00703" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66798450cdc32521","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
